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Abstract 
Jonathan Robert Gabriel 
HIGH THROUGHPUT ANALYSIS OF THE PENETRATION OF IRON 
OXIDE/POLYETHYLENE GLYCOL NANOPARTICLES INTO 
MULTICELLULAR BREAST CANCER TUMOR SPHEROIDS 
2015-2016 
Vince Beachley, Ph.D. 
Master of Science in Mechanical Engineering 
 
 
      The purpose of this study was to design and optimize a system for the 
high-throughput analysis of multicellular tumor spheroids (MCTS), and validate 
the system through the study of a complex biological model.  The system was 
successfully created and optimized, allowing the histological recovery of MCTS 
at rates up to 90% for microarrays of 24-spheroids.  Arrays of 96-spheroids were 
recovered at rates up to 86%.  The system was used to study the penetration of 5k 
Da-polyethylene coated superparamagnetic iron-oxide nanoparticles (5k-PEG 
SPIONs) into HTB-126 breast cancer spheroids cultured to a mean diameter of 
486 µm (± 25.2 µm).  Results were compared to an identical study using 2D 
cultures.  Positive staining for the SPION dosage of 100 µg/mL in 2D culture 
regardless of incubation time was observed along with a lack of staining for all 
other concentrations in both 2D and 3D.  SPION incubation led to necrosis in 
breast cancer spheroids after 3 days.  
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      Biomedical cell culture and analysis techniques developed in the first 
decade of the 19th century remain the chosen research methods in many 
laboratories of today.  Since this time, our fundamental knowledge of cellular 
and tissue biology has greatly changed; however, our analytical methodologies 
have failed to keep up to pace.  It is irrefutable that more efficient tools and cost-
effective methods are necessary to propel biology, specifically cancer biology and 
drug development, through the 21st century.  The widespread application of 
recent technological advances has the potential to improve outcomes for many 
patients now and in the future through improved drugs and personalized 
medicine. 
      It is unfortunate that the pharmaceutical industry is primarily a business 
and only secondarily a means for the improvement of humankind.  As a result, 
more economically favorable products may be pursued in place of developing 
those with the greatest potential to impact and cure disease.  This idea 
substantiates the need for developing testing platforms to produce better drugs 
more rapidly, while tailoring them to patient specific needs, at a fraction of the 
cost. 
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      The future of drug development lies in mechanistic approaches which are 
superior to their empirical counterparts in identifying novel therapeutic targets.  
Many assays for drug development have been developed, but no single assay can 
firmly predict the usefulness of a potential candidate.  We present a system, with 
the ability to interface with existing immunohistochemical techniques that is 
high-throughput and uses 3D culture systems as the fundamental diagnostic 
tool.  3D culture systems have been proven time and again to be far more 
relevant than their out-dated, 2D counterparts.  This is because 3D culture 
systems accurately represent the 3D tumor microenvironment consisting of cells 
and the surrounding extracellular matrix (ECM).  Improvements in cellular 
biology, tissue engineering, materials science, and micro/nanofabrication will 
only benefit the future of 3D culture. 
     In recent times, innovative discovery techniques have elucidated new 
drug targets leading to the development of novel compounds to act upon them.  
However, only about 5% of these compounds successfully progress through the 
development funnel, ultimately becoming useful treatments.  For every 5,000 to 
10,000 compounds in the pharmaceutical development funnel, only one will 
successfully make it to market.  In the United States in 2013, the Food and Drug 
Administration approved only 27 new medications; nine of these were orphan 
drugs.  The European Medical Agency did not surpass this to a great extent, 
3 
recommending 81 medications for approval (up from 57 in 2012).  Many drugs 
fail during the most expensive phase, phase III clinical trials.  The result is a cost 
of approximately $1.5 billion USD to bring a single drug to market.  This cost is 
necessary to make up for failed compounds in a company's pipeline.  One 
potential reason for the high attrition rate is the use of 2D culture by 
pharmaceutical companies as an initial screening tool.  The use of 3D cultures in 
the pharmaceutical business is likely limited, with little public evidence of any 
use.  Implications of 2D culture high-throughput screening (HTS) approaches 
include the passing of drugs which may ultimately fail, and the screening out of 
others which may have become truly beneficial.  Additionally, no two patients 
ever have the exact same disease state.  The term "cancer" refers to over one 
hundred different diseases with patient specific  genetic effects.  There exists a 
definite need for a system that can use a patient’s own cells, incorporate the more 
relevant 3D microenvironment, and have the ability to be tested and analyzed in 
a high-throughput manner.  The future of oncology therapeutics is 3D culture, 
and there is no reason that it should not be used ubiquitously in 2016. 
1.2. Objective 
      The objectives of this research were as follows: (1) to develop a system or 
process for conducting high-throughput analysis of multicellular tumor 
spheroids with the ability to acquire regionally based biochemical information, 
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and (2) to validate it through a complex biological model involving drug 
penetration, showing the power of the methodologies of the system. 
      The specific aims included: (1) a complete review of the current state of 
the field including rationale for 3D culture, spheroid generation methodologies, 
and analysis methods amenable to high-throughput testing; (2) optimization of 
procedures for the creation and analysis of a spheroid microarray including (a) 
microarray mold design and fabrication, (b) spheroid culture techniques, (c) 
spheroid harvesting and transfer techniques, (d) microarray fabrication reagents 
and techniques, (e) array processing reagents and methodology, and (f) 
histological sectioning and staining; (3) quantification of the effectiveness of the 
system through (a) determination of the number of spheroids recovered, (b) 
degree of tilt during sectioning of the microarray, (c) processing effects of 
histological samples, and (d) the value proposition of the system through time 
and money saved to a user versus conventional methods; (4) validation of the 
system's effectiveness through a 3D study involving two dosages and multiple 
time points to characterize the penetration of superparamagnetic iron-oxide 
nanoparticles into breast cancer spheroids, and compare these to a parallel 2D 
study; (5) develop an automated/mechanical system for spheroid transfer from 
culture plates to microarray mold to increase the speed of microarray fabrication 
and reduce the cost of the system. 
5 
      We hypothesized the system would be capable of recovering at least 90% 
of spheroids embedded into blocks of 24-wells through a range equivalent to 
one-third of the diameter of the initial spheroid, and at least 70% of spheroids 
from blocks of 96-wells through the same range.  We anticipate an increased 
efficiency of study greater than 1000% compared to conventional methods based 
on time and money saved.  We believe sectioning will occur in-plane with an 
error no greater than 100 micrometers of tilt over the length of the array (0.382 
degrees of tilt).  Finally, we anticipate dosage and incubation time dependent 
effects on nanoparticle penetration in the validation study, but are unsure which 
will have a more profound effect. 
      Future developments related to this project will (1) improve the design of 
the mold and process, pushing spheroid recovery above 95% for all array sizes, 
(2) fabricate a completely automated system capable of spheroid placement into 
the microarray, and (3) improve processing and histological techniques to section 
microarrays to 10 µm and below. 
1.3. Organization of Thesis 
      This chapter (Chapter 1) contains an overview of the motivations and 
objectives of the research reported in the thesis.  This chapter should act as an 
outline for the experiments performed, data and results expected, and rationale 
for said experiments. 
6 
      Chapter 2 is an in-depth and complete literature review on the current state 
of 3D culture and its implications for drug development and experimental 
biology.  Chapter 2 will be condensed and submitted to Pathology & Oncology 
Research as a review paper.  What differentiates Chapter 2 from other literature 
review papers on this topic is its focus on analytical methods for spheroids with 
the ability to acquire regionally based biochemical information without ultra-
expensive imaging equipment available only in top research laboratories.  The 
paper then proposes the methods discussed here as a prospective solution. 
      Chapter 3 consists of a thorough description of the methodologies 
invented, refined and analyzed to solve the problem of high-throughput 
immunohistochemistry of multicellular tumor spheroids (MCTS).  This chapter 
represents a bulk of the experimental work of the thesis.  The system is complete, 
fully characterized, and at a level of quality substantial for formal research.  
Recommendations for future iterations of design are recommended.  Chapter 3 
will be slightly modified and submitted to the journal Tissue Engineering Part C: 
Methods. 
      Chapter 4 contains a validation study for the system, with a comparison 
experiment between a 2D and a 3D culture system.  It is unfortunate that no 
publishable results were obtained from this preliminary study; however, it 
remains to show the power of the system, serving its purpose in this thesis.  This 
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study is currently under repeat and will be combined with Chapter 3 for journal 
submission. 
      Chapter 5 presents a solution for the mechanically automated transfer of 
spheroids between culture plates and the microarray mold.  Motivation for this 
chapter came as the result of suggestions from a recent grant review desiring 
more automation in the process.  This chapter covers the rationale, design, and 
functional procedure.  This chapter should be treated as confidential as it 
contains drawings and pictures of non-secured intellectual property. 
      Chapter 6 presents a conclusion of the work in this paper and 




A Review of 3D Spheroid Cultures as a Tool for Biomedical and Cancer 
Research: Needs, Rationale and Implications for the Future   
 
2.1. The Current State of Drug Development 
      Methods currently employed in biomedical research laboratories and the 
pharmaceutical industry to discover novel cancer therapeutics use often 
incorporate techniques developed in the first decade of the 19th century.  Only as 
recently as the 1970s has the industry seen a moderate shift towards more 
clinically relevant methods, methods involving the third dimension of cell 
culture [1].  More efficient tools and cost-effective methods are needed to 
conduct the preclinical screening of anti-cancer drugs to propel these 
technologies through the 21st century.  Unfortunately, many pharmaceutical 
companies operate around the basis of profit and do not necessarily produce the 
best possible treatments for patients, but those that are economically favorable.  
This idea substantiates the need to develop testing platforms that produce better 
drugs more rapidly, while tailoring them to individual needs of patients for a 
fraction of the cost. 
      There is a recent shift in the anticancer drug discovery process from 
empirical to mechanistic approaches [2, 3].  Empirical methods involve testing a 
9 
drug on a culture of cells and measuring the resulting viability1 of the cells 
without cognizance for the underlying mechanisms causing change.  Mechanistic 
approaches revolve around identifying molecular targets as the basis for drug 
design.  Recent research in genomics and proteogenomics has elucidated many 
new molecular targets for researchers and pharmaceutical companies to design 
therapeutic agents to act upon [4].  All drugs follow a similar process of design 
and development leading to their clinical use.  The process begins with 
identifying a druggable target as the result of a mechanistic or similar biological 
study.  Once the target is identified and characterized, in silico modeling is used 
to develop an array of lead compounds to act on this target.  These compounds 
are synthesized, beginning the pre-clinical testing.  Difficulties begin with sifting 
through large numbers of initial compounds using a set of standardized, high-
throughput screens.  Both in vitro analyses on appropriate cell lines, and in vivo 
studies on relevant animal models are performed.  Each drug is fully 
characterized using pharmacokinetic and pharmacological tests to determine 
absorption, distribution, metabolism and excretion properties.  Further 
cytotoxicity tests are performed to predict drug safety.  The tests determine 
potential therapeutic usefulness.  Compounds that successfully navigate pre-
                                                 
1 viability or another property that is a result of the entire culture’s population.  This is in 
comparison to a specific cellular event that can be tracked through biochemical analysis to 
individual cells or a specific organelle, protein, or gene across many cells. 
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clinical testing are employed in human clinical trials, the most important of all 
tests [1].  Many assays have been developed, but the ability of any particular 
assay to predict in vivo efficacy in humans has not been firmly established [4].   
      While biotech innovations have greatly increased the pool of potential 
new therapeutic compounds, only 5-10% of compounds reaching clinical trials 
successfully progress through development.  For every 5,000 to 10,000 
compounds entering the pipeline, only one will make it to market.  The large 
number of failures along the development process makes the cost of a successful 
compound greater than $1.5 billion USD in the 2010s [5].  Failure is generally due 
to either a lack of clinical efficacy or unacceptable human toxicity.  Clinically 
predictive in vitro models have obvious advantages in terms of their ability to 
save time and money.  Unfortunately, many of the current systems, including 
cell-based and xenograft models, are unreliable and non predictive of the 
pathophysiology they hope to represent; failure most often occurs during the 
latest and most expensive stages of testing, human clinical trials.  Therefore, it is 
absolutely imperative that more highly predictive, cell-based in vitro models are 
created to screen out poorly performing compounds earlier in the development 
funnel.  Eliminating useless candidates more quickly will reduce costs, wastes, 
and the ethical dilemmas associated with clinical trials, especially those of 
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failure.  Furthermore, it allows prioritizing the most promising candidates and 
accelerates their path to market [1]. 
      At this stage, assay methodologies are split into two distinct paths.  The 
first involves the automation and miniaturization of HTS to create ultra-HTS 
approaches, which are considered by some so distant to the in vivo environment 
that their outputs are relatively useless [4].  The other path involves creating 
assays of intermediate complexity to gain deeper insights to the mechanisms that 
operate at the cellular level.  Each set of assays has its benefits and limitations.  
There are three general categories based on the mode of operation and predictive  
capacities [4].  Generic cellular assays study the proliferation, viability and 
cytotoxicity in response to external stimuli.  These assays are more broad, but 
may provide confirmation for the continuation of a compound’s research.  
Failure at this step is not necessarily adequate grounds for disqualification.   
Other assays study signal transduction pathways such as ion channels, second 
messengers, and kinase activation.  The third class of assays study events at the 
genetic level with regards to transcription, translation and the regulation of such 
processes.  Unfortunately, none of these assays can definitively predict whether a 
compound’s candidacy should be pursued or terminated.  The current drug 
development process uses a combination of assays to build a library of potential 
new compounds that will move on to the next step.  Surely many promising 
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compounds may be left behind.  Additionally, we know that many compounds 
passing this stage will fail, costing the system millions of dollars.  The lack of 
clinical value of these assays may be attributed to the fact that 2D systems do not 
accurately predict the 3D environment. 
      Developments in 3D culture techniques have paralleled research in tissue 
engineering, hoping to more accurately represent the 3D microenvironment.  
Some techniques able to create reproducible cultures exhibiting viability and 
differentiation from isolated primary tissue include spinner flask culture, various 
perfusion and fed-batch techniques, and the tumor fragment spheroid model [4].  
These methodologies will be discussed further in 2.6 Three Dimensional Culture 
Techniques. 
      Currently, there exists an effort to develop tumor specific testing 
platforms that employ the patient's own primary cancer cells.  The result is a 
highly individualized test which attempts to recreate the specific disease 
pathophysiology of the individual patient.  One example of these tests is the ex 
vivo ATP-based chemosensitivity assay.  Unfortunately it relies on the 2D 
culturing of tumor cells isolated from primary tissue biopsies [6].  Problems with 
this method include a limited number of useful cells extracted from the biopsy, 
and the potential modulation of cell morphology upon expansion in 2D culture.  
Here, we see a definite need for a system that can use a patient’s own cells, 
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incorporate the more relevant 3D microenvironment, and have the ability to be 
tested and analyzed in a high-throughput manner. 
2.2. The Need for In vitro Models with Increased Physiological Relevance 
      There is an increased demand for in vitro models that capture more 
complexity than what is observed through 2D monolayer culture [7].  It is firmly 
established that 2D monolayer culture does not accurately represent the in vivo 
micromilieu.  The development of tissue and quasi-organ 3D in vitro models 
from human cells have the potential to “bridge-the-gap” between standard 
monolayer culture, and more complex models such as animal and human testing 
[7].  The best method for creating 3D cell structures has yet to be determined, but 
it is speculated that better drugs will be developed as a result of testing on more 
realistic systems [1].  Initial "stop/go" decisions in the drug development process 
are often made after tests on monolayer cultures.  These are not the most 
physiologically relevant [1].  For the pharmaceutical industry, it is imperative to 
screen out poorly performing compounds at the earliest possible stages for cost 
effectiveness.  Many researchers believe the best way to improve in vitro 
screening of candidates is to use 3D multicellular tumor spheroid (MCTS) testing 
as a critical part of the process [1].  Since many treatments lose their efficacy in 
the 3D environment, spheroids are thought to be a tool for negative selection, 
identifying compounds that perform poorly in vivo.  More recently molecular 
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targets and signaling pathways have been found to play a role exclusively in 3D 
making the spheroid model a positive selection tool in drug development 
initiatives [8-12].  
      2.2.1. Predictive capacity of animal, xenograft and humanized models is 
limited.  Many reports have stated the limited predictive value of routine drug 
screening tactics [3, 13, 14].  This information adds additional support to the need 
for developing more complex 3D models to adequately mimic the in vivo 
pathophysiological environment in hopes of forever replacing monolayer culture 
and animal testing [4].  The optimization of preclinical and pre-animal testing 
systems will alleviate economical burdens while also diffusing ethical concerns 
associated with clinical testing.  Additionally, improved tests will optimize and 
streamline the selection of clinically effective drugs from the growing pool of 
potential candidates [4].  The US National Cancer Institute Developmental 
Therapeutic Program uses a few different multi cell-line screens, and one hollow 
fiber model, to predict xenograft activity.  Xenograft models involve 
transplanting human tumors into immunodeficient animals, and studying the 
effects of the drug on the tumor.  These types of models are thought to be one 
step closer to human models than standard animal testing, although they do 
come with drawbacks such as unnatural biochemical interactions, and 
significantly different, compromised immune systems.  As for the cell line 
15 
models, it was shown that the 60-cell line screen was slightly more predictive 
than the hollow fiber model in determining which compounds should proceed to 
animal and xenograft testing.  However, no significant correlation was shown 
between any single in vitro or in vivo preclinical model and actual clinical results 
[4]. 
      Rodent models will still be necessary for pharmacokinetic2 and 
toxicological3 evaluation of potential new therapeutic agents for decades.  
However, spheroids have the potential power to greatly reduce the number of 
animal models needed, and to delay their use in the process.  In this way, 
spheroids may not only alleviate ethical and economic concerns, but also make 
up for the fact that animal models are not very indicative of human in vivo 
testing results, and thus clinical efficacy [4].  MTSC models look to "bridge the 
gap" between 2D culture and animal/human testing by employing explanted 
human cells in a more natural, and physiologically relevant way.  Adding MTSC 
as a tool in the drug development arsenal will give researchers a stronger testing 
foundation and better information to move forward. 
      Animal models give researchers information that may not be discerned 
from any current in vitro methods, but they often fail to capture the in vivo 
response that is seen in humans.  For example, the number one reason for the 
                                                 
2 dosage, formulation, administration, and half-life 
3 both systemic and organ specific 
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failure of drugs in clinical trials is liver toxicity not predicted by animal models 
[15].  Furthermore, many pathogens and immune responses are species specific.  
One attempt to create a better model involves ‘humanizing’ mice.  Humanized 
mice are almost completely immunodeficient mice which show high rates of 
human cell engraftment, can support human tissue differentiation and growth, 
and generate well-differentiated multilineage human hematopoietic cells after 
hematopoietic stem cell transplantation.  These models are useful for studying 
human hematology and immunology in vivo.  More recently, genes have been 
introduced into these mice to allow for the production of important human 
cytokines with direct influence on the immunological response [16].  These 
techniques provide valuable information but remain expensive, challenging and 
have limits recapitulating the dynamics of the human body.  Questions have also 
been raised against the validity of these models as research has shown 
fundamental differences in telomerase regulation and cytokine compatibility 
between rodents and humans [15]. 
      2.2.2. The engineering journey to more predictive models.  To create 
increasingly predictive in vitro models, attempts must be made to replicate the 
functional hierarchy present in tissues beginning with microvasculature, as 
transport phenomena are crucial to understanding biological systems.  
Additionally, better models should recreate microscale flows through the 
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interstitial space, blood and lymphatic networks, and the apical ducts [7].  The 
challenge of recreating microvasculature remains a significant barrier to fully 
functional in vitro systems [7].  Microvascular considerations are important for in 
vitro models as these mechanisms govern the bulk transport of signaling and 
regulatory molecules, along with those required for sustaining life.  These flows 
lead to a profound impact on tissue proliferation, morphology, and 
differentiation in vivo.  This will be expanded upon further in Section 2.4, The 
Mechanical and Chemical Properties of the In Vitro Microenvironment and their 
Influences on Cellular Biochemistry. 
      The use of a patient’s primary cells for in vivo testing is preferable but 
limited by availability.  Primary cells have a reduced ability to expand and are 
largely variable in morphology.  Studies involving human primary cells may also 
be hindered by ethical considerations [4].  The lack of primary human material is 
the limiting step for high-throughput screening (HTS); systems employing 
established cell lines are considered secondary.  The result is a demand for more 
advanced in vitro test systems based on secondary cells in the pharmaceutical 
industry.  In tests with secondary material, generating the required number of 
cells is no longer an issue; however, tests involving secondary cell lines in place 
of those using primary cells may not accurately represent the pathophysiology of 
the patient’s specific disease state [4]. 
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      The field of stereolithography has accelerated allowing researchers to 
fabricate well toleranced materials into the low end of the microscale range.  
These systems are able to produce scaffolds large enough (0.1 - 10 cm) with finely 
tuned features such as walls, pores, and channels adequate for cell penetration, 
proliferation, communication and pre-vascularization (0.2 - 11 mm).  In time, 
technology may improve to allow even finer features to facilitate the fine-scale 
cell organization truly necessary for in vitro tissue engineered models.  Some 
manufacturing systems are emerging that allow the necessary resolution to move 
into the nanofabrication territory, but these technologies must be properly 
adapted to work with biological systems [7]. 
      Many researchers recommend a collaborative environment between 
academic institutions and the pharmaceutical industry to prove the predictive 
value of 3D systems, while optimizing use and allowing for integration into the 
current drug development process.  Advances in tissue engineering, such as the 
creation of bioreactors and 3D scaffolds, have created numerous new 3D culture 
technologies.  More work must be done in fully characterizing each of these 
systems and evaluating their individual potential to replicate necessary functions 
of pathological tumors in vivo [4]. 
      “A principle component of this failure results from our lack of 
understanding of, and inattention to, how to culture cells specifically so that they 
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phenotypically represent their in vivo counterparts” [17].  It is accepted without 
dispute that cells behave in accordance to their environment and culture 
conditions.  Altering factors such as culture mediums and supplementation, 
initial cell density, and culturing surfaces and techniques leads to high variability 
in quantitative and qualitative outputs such as proliferation, differentiation, 
migration and apoptosis4.  It is believed that each of these factors affects both 
random and target-specific screening approaches, creating a “butterfly effect” of 
cell culture.  Further understanding of the cellular microenvironment and its 
impact on cellular phenotype is necessary to design increasingly accurate 
models. 
2.3. Two Dimensional Cell Culture and its Limitations 
      The fundamental principles of cell culture were first developed in 1907 by 
Harrison and colleagues, who showed sustained cell maintenance outside the 
original body of origin.  Specifically, pre-differentiated neural tissue was taken 
from frog embryos and placed in a drop of lymph.  The solution was hung off a 
sterile coverslip in a moist environment and cultured for some time.  This setup 
was actually quite similar to initial methods of hanging drop culture, occurring 
much later in the century.  Since its inception, almost every step of the cell 
culture process has been optimized.  Developments include culture containers 
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coated with optimal chemicals for cell attachment and synthetic culture mediums 
that outperform their blood plasma predecessors.  Additionally, new culture 
mediums are cheaper, reproducible and antigen free.  Antibiotics and antifungal 
agents have been developed to mitigate potential contamination sources arising 
during normal culture.  Small iterations over past decades have improved 
culture techniques, while the internet has made vast knowledge bases available 
to any research laboratory wishing to join the quest [1]. 
      Traditional methods of culture involve the growth of a cell monolayer in a 
flat culture vessel, typically a flask or Petri dish.  Culture chambers are made of 
plastic and coated with substrates to aid cellular attachment.  Cells are grown in 
a mixture of culture medium, serum and antibiotics.  Other additives such as L-
glutamine and insulin may be added depending on the needs of a specific cell 
lineage.  Additionally, the cell medium may contain phenol red as a pH 
indicator.  Phenol red transitions from yellow to red between pH values of 6 and 
8.  The ideal eukaryotic cell's physiological pH is tightly regulated between 7.35 
and 7.45.  Therefore, fresh culture medium appears red and turns orange-to-
yellow when acidic metabolites accumulate.  Medium must be changed before 
the solution becomes fully yellow in color.  Cultures are incubated at 
physiological temperature of 37ºC for optimal enzyme activity and 5% CO2 
saturation to maintain bicarbonate concentration for cell pH buffering systems.  
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Once cells reach confluence, they are detached from the culture flask using 
trypsin and/or ETDA, and reseeded in a new flask at approximately 10% of the 
confluent concentration.  This is called sub-culture.  It is performed to prevent 
cell senescence and nutrient exhaustion.  The process of sub-culturing a line of 
cells increases its passage number by one.  It is important to keep track of the 
number of passages as some cell lines lose proliferative and viability capabilities 
as well as important morphological characteristics at passage numbers as low as 
five [1].  Many cancer cell lines have been immortalized meaning their genes 
have been engineered for indefinite proliferation without the loss of viability.  
The cells of Henrietta Lacks, who died in 1951, have been around since the 1950s 
and are still used today. 
      The need to create in vitro assays which produce biomedically relevant 
information is essential for drug development.  2D cell culture has been 
conventionally used for drug candidate testing; however, it has been shown that 
the correlation between successful navigation of 2D tests and useful therapies is 
limited to none [1].  For this reason, many researchers suggest new 
methodologies for screening compounds be developed and tested. 
      Limitations of 2D culture include the lack of cell-cell and cell-extracellular 
matrix (ECM) signaling that occurs ubiquitously in 3D cultures and in vivo.  The 
ECM is a collection of molecules secreted by living cells which provides 
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mechanical support and biochemical influences fundamental to the organization 
of tissues.  Such signals between neighboring cells and cells-and-ECM are 
essential to cell differentiation, proliferation and normal cellular functions [18, 
19].  One element lacking in 2D environments important for cell function is 
integrin interactions.  These integral membrane proteins help link the cells to 
their external environment through connections to actin, filamin and other 
proteins.  Through messenger systems they relay external information and 
biochemical cues to the cell.  As a result, it has been suggested that 3D in vitro 
systems such as MCTS may bridge-the-gap between 2D monolayer models and 
expensive in vivo testing [1]. 
      Recent developments in 3D culture technology and analysis have 
highlighted potential key differences between 2D and 3D culture.  When grown 
as monolayers, cells have been shown to have differences in cell morphology, 
polarity, receptor expression, oncogene expression, interactions with ECM and 
basement membrane, and overall different cellular architectures when compared 
to in vivo samples.  Confining cells to grow in a 2D space on artificial surfaces 
leads to the lack of tissue hierarchy observed in monolayer cultures [4].  Such 
findings question the validity and significance of studies performed on 2D 
cultures.  As a result, the field has shifted towards studying and improving 3D 
culture methodologies due to their superior physiological relevance [1].  
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Additionally, 3D cultures histologically to represent in vivo microcarcinomas to a 
high degree [4].  Figure 1 compares an in vivo tumor with a spheroid (MCTS) side 
by side.  Notice the many similarities in functional architecture between the two 
tissues.  One important difference is how they are perfused, the tumor from a 





Figure 1.  Immunohistochemical staining of spheroid sections (b,c,f)  next to sections 
of biopsied tumor specimens (a,c,e).  Reproduced from Kunz-Schughart (2004). 
 
 
      Another reason for the superiority of 3D culture is its ability to preserve 
the original phenotype and function of explanted cells.  For example, both 
primary articular chondrocytes and hepatocytes rapidly lose morphology upon 
monolayer culture.  In 3D, this loss may be attenuated or even reversed.  
Additionally, a study showed how multipotent mesenchymal stromal cell 
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(MSC)-derived hepatocytes were better able to perform important functions such 
as albumin and urea synthesis, as well as ammonia and drug clearance in 3D [4].  
This example is one of many providing evidence for 3D cultures as superior in 
vitro models to 2D monolayer culture. 
2.4. The Mechanical and Chemical Properties of the In Vitro 
Microenvironment and their Influences on Cellular Biochemistry - 
Requirements for Improved 3D Models 
 
      The extracellular matrix (ECM) may be thought of as the foundation of 
tissues.  It is constantly modified by cells to control mechanical and chemical 
properties of the microenvironment.  Mechanical properties of the ECM are 
controlled by the composition, architecture and the degree of crosslinking 
between various proteins and biopolymers [7].  Cells are able to finely tune these 
properties of local ECM to suit the needs of a specific tissue.  Accomplishing this 
requires the synthesis, secretion and incorporation of proteins like collagen into 
the ECM.  Collagen is one protein the cell uses to resist tensional stresses.  This 
protein, which is actually a heterodimer of interwoven proteins, acts as a 
molecular braided rope with a modulus of elasticity between 5 and 11.5 GPa at 
room temperature [20].   
     In order to resist compressional stresses using flexible and soluble organic 
molecules, the cell must be more creative.  Structural integrity under 
compressive loading is accomplished with the use of heavily glycosylated 
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proteins called proteoglycans.  Glycosylation is the covalent bonding of sugar 
molecules to proteins, lipids or other organic molecules.  In the case of 
proteoglycans, proteins are attached to glycosaminoglycans.  They contain many 
carbohydrate residues, specifically sulfate and uronic acid groups which are 
negatively charged at physiological pH.  The result of this negative charge is the 
attraction of partially positive hydrogen atoms present in water molecules.  
Ultimately, proteoglycans are heavily hydrated molecules which use the 
incompressible fluid, water, to resist compressional stresses.  The high charge 
density of proteoglycans makes protein transport throughout the ECM difficult.  
Dynamic compressive forces have been shown to control the deposition patterns 
of proteoglycans and protease inhibitors in chondrocytes [21].  This principle has 
been exploited in tissue engineering through the mechanical stimulation of 
cultures to promote chondrogenesis with good results [22].  Additionally, 
basement membrane, secreted basally by epithelial and endothelial cells, also 
hinders protein transport and acts to increase mechanical stiffness [23]. 
      Also incorporated into ECM are globular, or nonstructural, proteins which 
play important roles as enzymes and in chemical signaling.  Globular proteins 
control cellular events such as adhesion, migration and ECM remodeling, a 
process which occurs constantly in response to the external environment.  
Remodeling of the ECM to increase strength is just one example of how 
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mechanical stresses are coupled to chemical composition.  Furthermore, globular 
proteins help control cell migration, proliferation, apoptosis and differentiation.  
The large number of growth factors, chemokines, and other morphogenetic and 
signaling proteins secreted and embedded into the ECM during its synthesis 
assist cells in accomplishing these tasks.  Ultimately, the ECM controls the bulk 
and local mechanical environment and contributes to the tissue’s 
microenvironment, a microenvironment which is preserved to a much higher 
degree in 3D culture compared to 2D. 
      Production of ECM in spheroids has been described in a number of 
studies [24-29] and has been shown to be far more extensive in the amount and 
assembly compared to corresponding 2D cultures.  Production of ECM in tumor 
spheroids is different than in nonmalignant cells.  In tumor cells, ECM is 
predominantly of tumor cell origin.  In vivo, ECM is typically produced by non-
tumorigenic, stromal cells.  In MCTS, this is not the case.  Therefore, it is 
important to monitor the origin of ECM as this may be a factor in tumor 
initiation [26]. 
      2.4.1. Specific effects of external mechanical forces on cellular 
physiology.  Basal cellular phenotype is determined by integrating the numerous 
mechanical and chemical cues strongly coupled in the 3D environment.  The 
growth and regulation of connective tissues, such as muscle and bone, are 
28 
strongly influenced by mechanical forces.  Mechanical loads are transferred from 
the macro to the cellular level where they are transmitted to the ECM and cells 
integrated within.  This is one example of how molecular signaling mechanisms 
are directly coupled to stretch and compression.  These mechanisms may be 
easily lost in monolayer cultures adhering to a flat, rigid substrate.  Molecules 
involved include those attached to the ECM, and all types of other extracellular 
signaling molecules which respond to the mechanical stimuli: endocrine, 
paracrine and autocrine messengers.  For example, weight bearing exercises 
increase muscle mass and bone density; space travel has the opposing effects.  
These are physiological responses to external stresses, or lack thereof.   
      In addition to eliciting chemical responses, mechanical stresses physically 
change the spatial distribution of cells, ECM and effector molecules [7].  This 
occurs even in tissues without typical mechanical responsibilities.  Many of these 
signals are well understood on an individual basis, but the field of tissue 
engineering still looks to discover how signals modulate each other to create the 
responses observed in vivo.   The ECM also binds many growth factors and 
biological effector molecules.  It further influences the cellular microenvironment 
by sequestering molecules which otherwise would diffuse, creating local regions 
of higher concentrations.  The ECM can also act to slow diffusion of paracrine 
and autocrine factors due to its porosity.  In this way, the mechanical and 
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chemical structure of the ECM directly influences chemical signaling dynamics 
[7]. 
      A more complete understanding of the coupling effects between 
mechanical forces and chemical signaling will have profound impacts on 
regenerative medicine.   Additionally, since so many cues are present in the 
ECM, recreating this environment in vitro is difficult.  Isolating individual factors 
and determining unique responses also has limitations due to the variable 
composition of ECM between synthetic batches.  High-throughput analysis of 
multicellular spheroids composed of healthy human cells could be a key model 
for future studies on the coupled effects of numerous biological variables. 
      2.4.2. ECM stiffness and composition regulate cellular response and 
phenotype.  Matrix stiffness plays a key role in certain cellular processes such as 
endothelial organization.  During tissue remodeling, morphogenesis, and 
differentiation, cells exert stresses on the ECM.  Cells can contract the matrix to 
varying degrees depending on the number of integrin-ligand bonds and the 
architecture of the ECM.  Other factors such as cellular migration and 
intracellular tension may be affected as well.  Stiffer matrix creates increased 
difficulty of contraction and greatens energy expenditure.  A stiff matrix can 
promote endothelial organization while inhibiting other cellular processes [30]. 
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      Two hallmark characteristics of cancer tumors are the lack of ECM 
organization and increased matrix stiffness.  In cancer, the ECM network is often 
deregulated, leading to more malignant cellular phenotypes and metastases.  The 
elasticity of the matrix is also closely intertwined with its biochemical properties; 
a stiff matrix is often an indicator of disease.  Since sensing external forces 
involves the elasticity of the matrix, the ECM provides mechanical cues that 
influence cellular behaviors.  The cytoskeleton along with focal adhesion 
components, the nuclear matrix, and the nuclear envelope and chromatin act as 
the biomechanical sensors that determine how cells react to forces from the ECM 
[31].  For example, researchers showed how changes in mechanical forces are 
correlated with differences in TGF-β signaling in mouse tendon [32].  
Additionally, others showed how increasing the stiffness of mammary epithelia 
gels disrupted morphogenesis and enhanced proliferation through a mechanism 
of phosphorylation of focal adhesion kinases [33].  Matrix stiffness has also been 
shown to play a role in ECM contractions influencing healing and fibrosis [30].  
ECM composition and stiffness are important regulators of cellular response. 
      Swartz and colleagues aimed to show how mechanical stress can be 
communicated from stressed to unstressed cells in the coordination of the 
cooperative tissue remodeling process [34].  The study showed how mechanical 
stress on human airway epithelial cells could elicit a matrix remodeling response 
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in unstressed, co-cultured lung fibroblasts through soluble chemical signals.  The 
results challenge the accepted mechanism of fibrosis in asthma, which has been 
attributed to the effects of the inflammatory response.  However, it is now 
hypothesized that mechanical stresses also play a role in the fibrotic response.  
Results of the study concluded that epithelial-fibroblast interactions are complex, 
two-way cellular interactions where the presence of each cell type modulates the 
response of the other.  Additionally, they noted that since the ECM is deformable 
and that interactions between it and cells contained are coupled, the 
communication which arises due to these mechanical stresses should studied be 
more closely.  Since fibrosis and ECM stiffness are indicators of cancer, further 
studying these communication networks may be important to reveal the 
underlying mechanisms of the disease. 
      Another form of mechanical stress that influences the microarchitecture of 
tissues is shear stress from microvascular fluid flows.  Microvascular endothelial 
cells sense an increased need for fluid flow to a specific region due to higher than 
normal shear stresses.  Short term responses included increased recruitment of 
quiescent capillaries and if the situation persists, angiogenesis may result [35]. 
      In vitro models which contain two or more cell types may respond in 
different ways to mechanical forces than single-cell cultures.  First, cells may 
rebuild their local environment resulting in a new, shared micromechanical 
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environment.  For example, epithelial cells may stiffen the environment with the 
secretion of basement membrane.  The rebuilding of the environment may be 
coordinated between the signals of the multiple cell types.  Secondly, simply the 
presence of another cell type may modulate the expression of the other cell types 
present [36].  Spheroid co-culture studies have the potential to combine the 
power of typical co-culture studies, but in a more natural environment.  
Additionally, many cancer pathologies are a result of numerous cell types 
present in tumors leading to the observed pathophysiology.  
      Other molecules present in ECM such as adhesion molecules in the 
integrin and cadherin families are critical in determining a cell’s fate with respect 
to proliferation, life and death.  The apoptotic mechanism is closely related to 
contact with other cells, as are mechanisms associated with contact inhibition of 
proliferation [29].  An article published in the Oncology Review Editorial in 
emphasized the importance of using spheroids as a tool because “such a model 
of three-dimensional growth should bring a better understanding of the role of 
intercellular adhesion in dictating cellular fate” [29]. 
      2.4.3. Molecular gradients in 3D culture.  The composition of ECM and 
cells residing within is directly responsible for the accumulation of chemicals 
over time.  Most gradients, such as oxygen and nutrient gradients, may be 
measured and analyzed.  For some regulatory molecules such as epidermal 
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growth factor (EGF) and other cytokines, concentration gradients are difficult to 
measure because good input data is lacking.  Work in this area has progressed 
due to phenomenological observations in biology that require qualitative 
analysis.  One important finding is the idea that paracrine loops, once thought to 
be a hallmark of cancer, are now understood to be a cells’ probing mechanism 
into the local environment.  A cell uses autocrine loops to probe the 
microenvironment by sending out an array of molecules locally and analyzing 
the fraction of the signal returned.  It is hypothesized that this aids the cell in 
sensing tissue boundaries [37]. 
      Other molecular gradients exist including those of oxygen, glucose and 
other nutrients.  Tumor spheroids develop significant chemical gradients in 
cultures between 200 and 500 μm, with a secondary region of necrosis present in 
the center of spheroids greater than 500 μm.  It would appear that low levels of 
oxygen and glucose present in the central region should be the lead cause of 
necrosis, as initially hypothesized.  Experimental evidence suggests that these 
assumptions may not be true and that the concentration gradient for glucose 
itself is rather minimal [38].  However, another hypothesis is that the necrotic 
region develops naturally due to force balances and a gradual reduction of cell 
density occurring as a result of surface tension and stabilization factors [39].  
Regardless, this functional hierarchy of cells closely reflects the in vivo situation 
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of actively cycling tumor cells adjacent to capillaries while the inner region of 
cells become quiescent and die through apoptosis or necrosis [40], although 
quiescence is not a consequence of hypoxia [38].  There is no single, definitive 
factor leading to necrosis i.e. hypoxia, lack of nutrients, catabolites or hydronium 
ions creating a toxic environment. 
      One important feature of the spheroid model lies in its ability to 
metabolically adapt the central, necrotic cells to maintain intracellular 
homeostasis in response to stresses created from gradients [40].  Many features of 
cellular physiology are affected by these gradients such as proliferative and 
functional features, cellular RNA and protein expression, the distribution and 
function of biologically active molecules, and their penetration.  All of these 
factors lead to response to treatment [4, 40-42]. 
      In order to control the delivery of oxygen and reduce gradients, many 
different culture systems have been created.  One design includes cell-culture 
dishes with a semipermeable membrane.  The membrane elevates cells near the 
air-medium interface so they may be perfused in a region of higher oxygen 
concentration both from above and below.  There are also many different 
bioreactors including membrane-based, hollow-fiber, rotating drum, and 
perfusion bioreactors designed to combat these problems.  The pros and cons of 
each will be discussed further in section 2.6 3D Culture Techniques and Analytical 
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Challenges.  However, most of these systems are designed for creating masses of 
cells instead of finely controlled and reproducible 3D spheroids such as those 
created in this study. 
      2.4.4. Mechanical and chemical properties unique to spheroids.  Just as 
in any three dimensional tissue, concentration gradients can exist for any soluble 
molecule consumed or produced by a spheroid.  The two main competing factors 
influencing gradients are diffusion and convection.  Both mechanisms affect all 
types of molecules, but typically diffusion dominates in smaller molecules, and 
convection, or bulk transport, dominates the dispersion of larger biomolecules.  
There are two ways established concentration gradients may affect the cell or 
tissue.  First, cells in different regions of the 3D tissue may behave differently due 
to unique conditions experienced by each microenvironment as the result of the 
summation of numerous concentration profiles.  3D spheroid cultures therefore 
become a convenient way to study the changes along these gradients because of 
their spherical geometry.  Secondly, gradient dependent cell responses such as 
migration may occur which are important for modeling tissue organization and 
metastasis [7]. 
      Concentration profiles may be modeled mathematically by Fickian 
diffusion.  The mass transport equation, governing the relationship, is a balance 
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of diffusive transport and tissue consumption.  The resulting differential balance 
is 
              
   
   
 ,    (Equation 2.1) 
 where C is the concentration of the molecule in question, x is the distance from 
point of interest to the tissue surface, and Q is the volumetric consumption rate 
by the tissue.  Using zero order consumption,           , the solution 
becomes:  
                                                
 
  











  ,   (Equation 2.2) 
where C0 designates surface concentration, L is the distance of diffusion and ɸ is 
the Thiele modulus.  The Thiele modulus is a dimensionless coefficient which 
describes how tissue thickness, cell density (i.e. nutrient consumption rate), and 
surface concentration affect the resulting concentration profile as follows: 
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 , which means the concentration of the molecule 
in question at the surface of the tissue is half of what it was at the source (C0, 
L=0).  For    , significant concentration profiles develop within the tissue [7]. 
      The most important nutrient gradient to consider is oxygen, as it is rapidly 
depleted due to its low solubility in culture medium.  It may also be depleted in 
areas of high cell density due to large consumption rates.  Gradients of glucose 
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and amino acids are close to negligible due to their high concentrations and 
solubilities [43].  Oxygen gradients affect cells in multiple ways.  In addition to 
respiration, local oxygen concentrations regulate cellular redox states and affect 
signaling pathways.  Under high oxygen concentrations, these signaling 
pathways may create reactive oxygen species linked directly to DNA damage 
[44].   
      High oxygen concentrations also are toxic to many cells [44].  Significant 
oxygen gradients develop in tissues with high cell density and aggregates greater 
than 250 μm in diameter.  This may occur in aggregates of epithelial cells and 
islets behaving normally, but also in various tumor cells.  However, in stromal 
tissues which are more loosely packed only small, relatively insignificant 
gradients occur.  Additionally, it should be noted that even in a 2D monolayer 
culture, concentrations develop if the medium is unstirred.  At a distance just 2 
mm under the surface of the culture medium, the oxygen concentration drops 
between 50 and 90%, based on the density of culture and consequently the rate of 
oxygen consumption.  Conversely, low oxygen concentrations may promote the 
differentiation of stem cells leading to further changes in the local 
microenvironment [45]. 
      pH gradients also play a role in spheroid metabolism and are interrelated 
with oxygen gradients.  Although, both types of gradients are heterogeneous in 
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shape with respect to the radial axis of the spheroid, there is no direct 
relationship between pH and oxygen concentration at the local level.  However, 
strong correlations were found between mean pH and pO2 profiles [46].  Other 
studies looked to find differences between spheroids of various cell lines.  It was 
found that the quotient of ΔpO2/ΔpH was consistent across all spheroids of a 
given cell line.  Faster growing spheroids tended to have higher quotients such as 
those formed with human colon carcinoma cells (HT29).   Low quotient 
spheroids, such as those formed with grade IV glioblastoma cells (U-118 MG), 
were found to produce about 3 times as much lactate and consume 3 times less 
oxygen than HT29 spheroids.  This result highlights differences in metabolism 
between types of spheroids [47]. 
      One molecule known to create specific engineering challenges in 3D 
cultures is protein regulator molecules.  Protein regulator molecules have a more 
difficult time diffusing through a 3D spheroid culture.  For this reason, molecules 
such as epidermal growth factor (EGF) are often added to culture media in 
concentrations well above their dissociation constant, Kd [mol] [7].  This constant 
is a measure of a receptor’s affinity for its ligand and is the concentration 
necessary to achieve 50% of receptor binding.  Biochemically, this is important as 
a strong relationship between ligand concentration, dissociation constant and 
biochemical activation is present.  EGF binds to epidermal growth factor receptor 
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(EGFR) and the complex is internalized, removing the receptor from the 
membrane to inside the cell where it can no longer “sense” EGF.  Therefore, in 
order to achieve a relevant concentration of EGF in the center of a 3D culture, one 
must create a higher than normal concentration (>Kd) at the periphery of the 
tissue causing many receptors to be bound and internalized.  Consequences are 





Figure 2.  Spheroid gradient characteristics.  The image reproduces a defined 3D 
structure and uniform geometry of a spheroid alongside multiple assays showing 
molecular gradients present. Reproduced from Hirschhaeuser et al. Multicellular 




      2.4.5. Thoughts for the future.  Recreating identically the mechanical 
properties of the in vivo environment for testing purposes may not be necessary.  
In the case of scaffolds for wound-healing and regeneration, the job is simply to 
provide support and a reservoir of cells to facilitate natural processes.  Often it is 
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adequate to create scaffolds with geometries toleranced to tens or hundreds of 
microns, and then allow biology to do the rest [7].  In addition to the spatial 
distribution of cells on a scaffold, its chemical properties and composition may 
be controlled to more closely represent the natural environment. 
      When engineering the mechanical and chemical environment in a 
physiologically relevant way, what amount of precision is necessary?  Is it 
adequate to simply create some of the structures found in vivo, couple them with 
the dominant cues, and to allow biology to do the rest?  For example, cells secrete 
their own ECM and growth factors to impact and control tissue synthesis and 
organization.  The tissue engineering in vitro model may only need to produce an 
environment suitable enough for deposited cells to take over and turn the 
artificial niche into a more natural one for studying biology.  In this way, the 
power of biology is used for its own study.  Only time and further research in 
tissue engineering and regenerative medicine may fully answer these questions. 
2.5. Why 3D Culture? 
      “Keeping in mind the fundamental differences between monolayers and 
spheroids with regard to cellular sensitivity to various treatment modalities, 
tumor spheroids should be mandatory models in applied cancer research, for 
example in major programs for drug screening and development” [29].  Two 
dimensional monolayer culture appears to be an adequate environment for a 
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very select few number of cell types accustomed to growing as multilayered 
sheets in vivo.  Although, even in this scenario, cellular adherence to artificial 
substrates fails to reproduce the native environment.  A true basement 
membrane, along with vasculature, is lacking.  For example, epithelial cells such 
as keratinocytes and corneal epithelial cells may be adequately modeled in vitro 
in this manner [48].  Almost all other cell types should benefit from a culture and 
study in a more realistic environment. 
      Scientists have long understood how removing cells from the in vivo 
environment changes many important variables while also inducing atypical 
conditions.  Even though the cell is the most fundamental repeating structure in 
biology, the functional unit of tissue is recognized as cells plus ECM [19].  
Unique properties emerge from the synergistic effects of cells interacting with the 
ECM to form tissues, as discussed in 2.4.  For this reason, improving drug 
development requires studying the effect of compounds on tissues as a system, a 
methodology proven to be more indicative of the in vivo response.  Properties 
such as specialized cell-cell contacts, polarized morphology and attachment to 
underlying basement membrane help comprise the normal functions of a tissue.  
These functions are essential for proliferation, differentiation, survival and 
secretion, and may aid in drug resistance [49].  The goal of 3D culture is to 
produce the most in vivo-like structures possible to more accurately predict drug 
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response.  By including 3D culture into the drug development process, this 
technique can bridge-the-gap between simplistic in vitro 2D analysis and more 
complex animal models of disease.  Implications include rapidly increasing the 
speed of drug screening to potentially save large sums of money, and the ability 
to create more effective, less toxic therapeutic regimens [1]. 
      Experts in cell biology believe that 3D culture is a basic necessity for the 
development of therapeutics, a natural stepping stone before turning to whole-
animal studies [4].  Unfortunately, the use of rodent models is driven not by 
predictive capacity and scientific reasoning, but by regulatory and legal 
requirements, as well as strong clinical tradition.  By maintaining a large number 
of rodent models, the overall predictive power is increased.  No single model has 
substantial predictive power alone.  Since the cost of drug development increases 
significantly at the rodent model stage, screening out poor candidates with cell-
based models early in the process has been a long-standing strategy.  Improving 
the power and capacity of these cell-based models to eliminate toxic and 
nonfunctional compounds could effectively streamline the entire process.  Cell-
based approaches will remain an important part of the process as they are low 
cost, take less time and use intact cells as a good representation of living patients.  
Cell-based approaches are important because they capture responses not 
observed in rodent models.  Multicellular tumor spheroid cultures are an ideal 
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testing platform of intermediate complexity, fitting logically between monolayer 
culture and in vivo animal systems. 
      Testing potential drug candidates should involve the most natural in vivo 
representation possible with respect to the spatial arrangement between cells and 
ECM, the resulting interactions, and other biological factors which influence the 
microenvironment.  Three dimensional culture techniques have been used by the 
biomedical community in studying organogenesis and tumor progression since 
the first half of the 20th century.  Today, it is well known that 3D culture is 
highly superior because it can restore biochemical and morphological features 
lost through 2D monolayer and suspension techniques.  Unfortunately, the full 
potential of 3D culture has been ignored until recently.  Supporting research in 
3D culture technology, the National Cancer Institute has developed a program 
called Signatures of the Cancer Cell and its Microenvironment.  It awards $40 
million per year for research aiming to increase understanding of the relationship 
between microenvironment and tumor pathology.  During this program, 3D 
culture will be emphasized in hopes of making its use more widespread in the 
scientific community [4].  Seemingly, it does not make sense to study organs and 
tissues using a homogenous cell population as is often employed in 2D culture.  
3D tissues do a better job of mimicking the complex structures and relationships 
of vessels, nerves and stroma, and can do so while incorporating the numerous 
45 
cell types present to the in vivo situation which are known to modulate each 
other. 
      2.5.1. Elucidation power of spheroids through biological mechanisms.  
Spheroids are widely used in biology for their ability to provide a 3D in vitro 
model to study proliferation, death, differentiation and metabolism of tumor 
cells in response to radiotherapy or chemotherapy.  It is also believed that 
including spheroids in high-throughput analyses during the drug delivery 
pipeline could greatly expedite the process of developing new therapeutics.  
Generating spheroids takes 24-48 hours, potentially longer depending on cell 
line, and creates cultures with homogeneous sizes, morphologies, and a specific 
regionally based pattern of cells.  This pattern includes cells at different points in 
the cell cycle with regards to growth and arrest.  It consists of a stratification of 
proliferating cells at the rim of the spheroid, and hypoxic, necrotic cells in the 
core of the tissue, with a region in between of quiescent cells [50].  These 
differential cell cycle states are also realized when observing in vivo tumor 
pathology. 
      However, most cell types require cues from an environment that is similar 
enough to the native 3D arrangement in order to respond in a physiologically 
relevant way.  Adding a third dimension to cell culture allows cells to receive 
external mechanical inputs for cell adhesion and attachment in all planes.  This 
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affects integrin ligation, cell contraction and intracellular signaling, all of which 
are important to the life of a tissue and rooted in the ECM [51].  Spheroids make 
a great tool for probing cell-cell and cell-matrix interactions through tissue-based 
mechanistic assays because they replicate a specific cellular niche.  They have 
assisted the investigations of biologists in elucidating the roles played by 
adhesion molecules in tumor pathology [52]. 
      The third dimension also allows chemical signals to affect the cell in a 
more natural way.  For instance, the 3D matrix binds important molecules such 
as growth factors and enzymes.  Normally in a tissue, these molecules occur in 
gradients which may not be present in 2D, eliciting specific cellular responses.  
Evidence has also shown that the 3D environment may be necessary to study 
remodeling events, such as epithelial acinar duct formation, occurring over 
longer-length time scales [19]. 
      Just like with nutrients such as oxygen, treating cultures with a 
chemotherapeutic drug creates a concentration gradient between the central and 
peripheral regions of the spheroid [53].  In vivo tumors develop similar gradients 
due to poor drug uptake by the tumor or poor distribution within the tumor.  
The rate of diffusion into tumors is a clinically significant factor with respect to 
the efficacy of treatment [54].  As a result, basic pharmacokinetic features should 
be replicated in cell-based assays for optimal relevance. 
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      Spheroids have also been used as a tool to investigate cell-matrix 
interactions.  Spheroids have played an important role in investigating a new 
immune-activation phenomenon called nemosis.  Nemosis is programmed cell 
death in activated fibroblast spheroids without the normal apoptotic markers, 
but accompanied by the production of cyclooxygenase (COX) 2, proteinases and 
proinflammatory cyto- and chemokines [55].  Knockout studies, or those 
blocking fibronectin receptors, have shown that nemosis is initiated by integrin-
fibronectin binding and regulates fibrocyte spheroid formation [52]. 
     Other novel proteins, such as the gap junction proteins connexins and 
pannexins, have been studied using spheroids.  Spheroid studies using the C6 
glioma cell line have shown the ratio of Panx1 to Panx2 proteins determines the 
degree of packing of cell aggregates.  In addition to recapitulating cell-cell 
interactions, spheroids also better represent morphogenetic movements such as 
tissue contraction and condensation [52]. 
      2.5.2. Mechanism of drug action and culture environment have 
profound effect on resulting therapeutic capacity of drugs.  There is a 
difference in resistance to apoptosis and chemotherapeutic drugs with spheroid 
cultures compared to monolayer cultures.  This fact supports the hypothesis that 
differences in culture environment can affect how cells respond to drug 
treatments [1].  One specific study by Tung et al. [56] highlights how drug 
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mechanism of action and the culture environment can have a profound effect on 
drug efficacy, and thus the resulting viability of remaining cultures.  In the first 
study, 5-fluorouracil (5-FU) was applied to both 2D and 3D culture at the same 
concentration of 10 μM.  5-FU is a thymidylate synthase inhibitor which blocks 
the synthesis of pyrimidine and thymidine necessary for DNA replication.  The 
overall effect is a reduction in cell proliferation.  The drug reduced 2D cultures to 
only 5% viability after 96-hours of treatment while 3D cultures remained at 75% 
viability after identical treatment.  It was concluded that the 3D spheroids were 
better able to resist the anti-proliferative effects of the 5-FU through multicellular 
tumor resistance.  Multicellular tumor resistance reflects the intrinsic drug-
resistant phenotype of most solid tumors, and it is the ability for a cluster of cells 
to better resist therapeutic attempts through limited drug penetration and a 
reduced number of proliferating cells as drug targets.  Almost all conventional 
cytotoxic anticancer drugs are less effective at killing MTSC than monolayers of 
tumor cells [9].  
      Tirapazamine (TPZ), a hypoxia activated cytotoxin, was tested in an 
identical manner.  In 2D culture, cell viability was reduced to 72% after 96-hours 
while in corresponding 3D cultures, viability was reduced to 40%.  The opposite 
effect compared to 5-FU was observed as 2D cultures were more resistant to the 
drug.  Since 3D spheroids generally have hypoxic cores due to limited oxygen 
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diffusion, the finding of increased therapeutic efficacy in spheroid culture 
supports the mechanism of action.  Up to 60% of in vivo solid tumors have 
hypoxic regions within their structure, further supporting the use 3D spheroid 
models as testing platforms in drug development, and showing how this region 
can be used as a drug target.  The study highlights how culture methods can 
drastically alter the effect of a drug on cells.  It also shows that 3D cultures are 
not necessarily more resistant to all drugs, and drug resistance is a combination 
of the specific drug and the cellular environment where its effects take place [56].  
Furthermore, the study highlights how a potential drug candidate may be 
screened out early in the development process if only tested in 2D, thus 
emphasizing the importance of testing drugs in the more realistic 3D 
environment. 
      Differences between 2D and 3D culture were noted in SKBR-3 cells which 
overexpress the oncogene HER2 [57].  Cells grown as spheroids using the forced-
floating p-HEMA-coated plate method had HER2 homodimers form [58].  In 2D 
culture, the same cells formed HER2 heterodimers with HER3.    Further 
differences in 3D culture included reduced epidermal growth factor receptor 
(EGFR); enhanced phosphorylation of HER2, HER3 and EGFR; and the 
downregulation of activated protein kinase B, an important protein in 
metabolism, apoptosis, proliferation, transcription and migration.  Additionally, 
50 
it was shown that trastuzumab has a significantly differing effect on cells grown 
in 2D versus 3D.  Trastuzumab is a monoclonal antibody used to treat breast 
cancer which binds the overexpressed HER2 receptor.  The drug leads to cell 
arrest during the G1 phase of mitosis and reduces cell proliferation.  The study 
showed that proliferation was reduced by 48% in spheroids but only 16% in 
monolayer culture, suggesting differences in signaling patterns between the two 
tissue architectures, specifically, altered phosphoinositide 3-kinase (PI3K) and 
mitogen-activated protein kinase (MAPK) signaling [40]. 
      Further examples of differing results in 2D versus 3D have been noted.  Li 
et al. showed that MCF10A cells (fibrocystic, non-malignant breast cells) cultured 
in 3D exhibited a higher resistance to doxorubicin, a drug which inhibits the 
unwinding of DNA for transcription, compared to those grown in 2D.  Cell lines 
SA87 (brain derived, metastatic breast cancer), NCI-H460 (large cell lung cancer) 
and H460M (metastatically derived from pleural effusion, large cell lung cancer) 
grown in 3D all have higher resistance to 5-FU and doxorubicin than those in 2D 
[59].  Finally, 3D cultured MCF-7 cells (breast cancer) treated with tamoxifen are 
more viable than those grown in 2D and treated with the same drug 
concentrations [60]. 
      Culture environment also strongly influences the resulting cellular 
physiology.  One study showed that culturing breast-epithelial cells on ECM 
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restored some mammary-specific gene expression not observed during culture 
on standard polystyrene plates [33].  Another study [19] showed how the 
organization of the microenvironment could contribute to different cellular 
responses due to the same biological factor.  In the study, both non-malignant 
and malignant HMT-3522 breast cells were grown in 3D using Matrigel.  The 
non-malignant cells organized normally, forming polarized acini as observed in 
vivo.  The cancerous cells formed disorganized, loose aggregates.  Both 
populations were then treated with antibodies against β-integrin, an 
overexpressed surface receptor in the malignant cells.  β-integrin caused 
apoptosis in the healthy cells; however, it caused an apparent reversal of 
phenotype in the cancerous cells back to the normal cell type.  This occurred to 
the point that the two cell populations became indistinguishable.  The 
experiment was repeated in 2D and this result was not observed.  This showed 
how extracellular cues can affect cellular phenotype.  It was hypothesized that 
cellular phenotype was dominant over genotype in this situation [18]. 
      2.5.3. Additional applications of MCTS cultures.  Spheroids are often 
spoken of in terms of developing cancer therapeutic drugs; however, the 
technology is applicable to other disease states and treatment modalities.  
Spheroids have been employed as models for a myriad of other therapeutic 
techniques including radiotherapy, chemotherapy, radioimmunotherapy, cell- 
52 
and antibody-based immunotherapy, hyperthermia, gene therapy, and 
photodynamic treatment.  Additionally, MTSC have been routinely employed in 
studies regarding the microenvironmental regulation of proliferation, viability, 
energy metabolism, nutrient metabolism, invasion, cell-cell interactions, and 
ECM composition [61]. 
      Further uses for spheroids include the investigation of specific host-tumor 
cell interactions including evasion as well as evaluations of normal cell injury 
due to tumor cell presence.  A technique used to study this involves growing 
spheroids and placing them on monolayers of confluent fibroblasts or 
endothelial cells with an underlying ECM.  Conversely, fibroblast spheroids may 
be cultured in tumor cell suspensions to study tumor cell invasion/migration.  
This technique also allows for the study of tumor cells which do not form 
spheroids on their own.  Incubating tumor or stromal spheroids with immune 
cell suspensions likewise allows the study of immunological response in vitro 
such as migration, differentiation and activation.  These co-culture systems have 
been employed to study the interactions between cancer cells and their cellular 
environment, and have the potential to be applied to study simplified versions of 
any biological system.  It may be ideal to use these advanced types of systems to 
gain a fuller understanding of drug sensitivity as well as to screen for agents that 
affect the host-tumor interaction. 
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      2.5.4. The rationale for MCTS in HTS approaches.  While generating and 
maintaining 3D cultures may be more labor-intensive than 2D, the tradeoff is 
that incorporating spheroids into in vitro drug efficacy and toxicity testing will 
probably yield more accurate versus monolayer culture alone.  3D culture will 
allow the more rapid selection of lead compounds worth pursuing [1].   
      The rationale for using spheroids can be lumped into four specific points.  
The first is that spheroids recreate the morphological, functional and mass 
transport phenomena of similar tissues in vivo.  Specifically, cells in spheroids 
restore the observed in vivo differentiation pattern for several weeks of culture.  
This recapitulation of in vivo function is not only relevant for modeling the 
pathophysiology, but also is useful for studying penetration, binding, and 
bioactivity of drugs.  The morphology of spheroids is close to that of 
experimental tumors in mice and natural tumors in humans, before 
neovascularization occurs [3]. 
      Secondly, MCTS approximate the growth kinetics and microenvironment 
of avascular tumor nodules, micrometastases and intervascular regions of large 
solid tumors.  The Gompertz equation is used to predict tumor growth in vivo [4].  
It has been shown, along with multiple other biologically based mathematical 
models, to analogously predict spheroid growth in vitro.  MCTS exhibit two to 
three distinct morphologies, depending on the diameter of the culture.  A 
54 
proliferation gradient is observed which begins with a layer of proliferating cells 
at the periphery, a layer of cell-cycle-arrested cells stuck in the G0 phase in the 
middle, and in cultures larger than 400-500 μm a hypoxic, necrotic core.  As 
previously discussed, oxygen and nutrient gradients develop inward, while 
catabolite gradients outward, just as observed in tumors in vivo.  These play 
important roles in how tumors respond to drugs. 
      The third benefit of using spheroids is that their spherical symmetry 
allows for a direct comparison between structure and function.  Specifically, 
microenvironmental gradients, biomarkers and cell morphologies can be 
spatially correlated to changes in cellular physiology.  There are three ways that 
this can be very useful.  The first advantage is that assays can be directly related 
to a specific region of the spheroid either through in situ histological analysis or 
by harvesting cell subpopulations for further analysis.  Additionally, the 
spherical symmetry allows for simplistic, theoretical predictions to radiation 
response, drug penetration and binding, or the interpretation of typical studies 
such as cell viability and proliferation.  The third advantage is the ability to 
create large groups of individual, identical cultures as long as a homogenous cell 
population is used with constant external culture conditions [4]. 
      Finally, spheroid culture can be adapted to allow for the coculture of 
multiple types of cells.  Of most interest is the coculture of cancer cells along with 
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one or more noncancerous stromal cell types such as fibroblasts, endothelial cells 
or hematopoietic cells.  Co-culture systems have not been extensively 
characterized but have the potential to be even more relevant than single-cell-line 
systems.  Understanding the relationship between healthy and cancerous cell 
populations is necessary in the study of disease progression, as these 
relationships play important roles in tumor pathology. 
      The chief scientific officer of a major pharmaceutical company was quoted 
saying, “In 10 years, anyone trying to use 2D analyses to get relevant and novel 
biological information will find it difficult to get funded.”  A paper published in 
Critical Reviews of Oncology in 2000 stated, “Notably, spheroids seem to be the 
appropriate model to study novel hypoxic markers, targeted therapy, 
multicellular mediated drug resistance, and heavy ion irradiation” [3].  
Researchers and academics at the precipice of new technology have been waiting 
patiently for this technology to become widely adopted, and now is finally the 
time where we are beginning to see such shifts in biomedical research take place. 
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2.6. Three Dimensional Culture Techniques 
      MCTS were originally adapted to cancer diagnostics in the early 1970s by 
Sutherland and associates [62].  This model is still used throughout research labs 
and has the most potential for application to HTS systems in anticancer drug 
development.  MCTS have greatly contributed to our knowledge of cellular 
response and, possibly more profoundly, have allowed researchers to 
understand the “microenvironmental regulation of tumor cell physiology” [63].  
Initial methodologies for generating spheroids involved placing a drop of cell 
suspension on the lid of a standard Petri dish and then inverting it.  The lid, with 
up to a few individual drops, was placed back on the dish containing a liquid 
such as media or PBS to keep the environment humid during culture.  Since the 
1970s, methodologies have rapidly improved alongside developments in 
electronics and control systems, micro manufacturing, and chemical engineering. 
      2.6.1. Forced-floating methods.  Spheroid formation may be induced by 
preventing a solution of cells from attaching to the culture vessel surface leading 
to self-adherence.  Forced-floating methods prevent this by modifying the 
surface, thus promoting cell-cell contacts and spheroid organization [64].  Some 
coatings used to prevent attachment include 0.5% poly-2-hydroxyethyl 
methacrylate (poly-HEMA) and 1.5% agarose.  The benefits of this method are 
reproducibility, uniform spheroid size as a result of identical initial cell 
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concentrations, compatibility with high-throughput testing, and the ability for 
long-term culture.  However, some drawbacks include the time it takes to coat 
the plates, costs of purchasing pre-coated plates, and difficulties with media 
changes [42, 50, 65]. 
      2.6.2. Agitation-based approaches.  There are two main types of agitation-
based approaches: (i) spinner flask bioreactors [65, 66] and (ii) rotational culture 
systems [67].  Both systems involve placing a cell suspension in a large vessel 
which is kept in motion through stirring or rotation of the vessel walls.  In this 
way, cells do not adhere to the vessel walls, but come together through cell-cell 
interactions [68]. 
      Spinner flask bioreactors are employed as a simple technique which can 
create many spheroids very rapidly.  This technique excels in long-term growth 
of cultures requiring media changes.  The motion of the flask is also thought to 
aid in mass transport of nutrients and wastes.  One particular drawback of this 
culture technique includes the exertion of shear forces on aggregates due to 
constant stirring.  This may elicit mechanochemical responses and affect the 
natural physiology of the cells.  Additionally, spinner flasks use large amounts of 
media and produce a broad range of spheroid sizes requiring the difficult task of 
sorting the resulting tissues for drug screening assays [64].  To combat this issue, 
spheroids may be initially formed using a forced floating or hanging drop 
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technique and then placed in the spinner flask for long term culture [69].  This 
method ensures a more uniform spheroid size and allows for environmental 
control over nutrient and oxygen exchange during extended culture.  However, 
the spheroids still must be replated into 96- or 384-well plates for assay, creating 
many extra steps in the process. 
      Instead of using a stirring mechanism, rotating cell culture bioreactors 
function by rotating the culture container itself.  These were initially developed 
by NASA in 1992 to mimic microgravity and exert low shear forces in culture.  
The culture chamber, which screws onto a rotator, is slowly rotated along its 
horizontal axis.  The result is the ability to keep cultures in the center of the 
vessel, preventing attachment to walls.  Low shear forces are the main advantage 
of this system.  The speed of rotation can be increased over time as spheroids 
become larger and fall through the medium faster.  Further advantages and 
limitations are the same as in spinner flask bioreactors; rotating bioreactors use 
simple methods, enable the production of a large number of spheroids, and 
allow for long-term culture with easy media changes with little ability to control 
the size of spheroids generated. 
      2.6.3. Microfluidic cell culture platforms.  Most microfluidic culture 
systems only support 2D culture which is arguably no longer relevant [70].  
However, some researchers described a system allowing 3D culture with 
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collagen-matrix interactions and imaging in three spatial dimensions.  The 
system works by passing a cell suspension through an array of micropillars.  
Cells aggregate inside the pillars and the spheroids are perfused by the passing 
culture medium.  Once a certain level of 3D structure is achieved, collagen is 
passed through the system fixing the cell structures and allowing for cell-matrix 
interactions [71].  The benefits of this system include the ability to work with 
high-throughput testing, high content analysis due to imaging capabilities, and 
minimizing reagent volume.  Limitations of the system include the lack of 
opportunity to retrieve and extensively characterize the spheroids formed [71].  
Other similar systems like this exist and may ultimately challenge currently 
employed systems as they allow for a finer degree of control over nutrient and 
drug administration while allowing for imaging without intermediate steps. 
      2.6.4. Matrices, scaffolds and the tumor fragment model.  Since cells 
naturally interact with ECM in vivo, it stands to reason that 3D culturing methods 
allowing cell-ECM interactions would better reproduce the natural cellular 
environment.  Matrigel is a commercially available ECM derived from 
Engelbreth-Holm-Swarm (EHS) mouse tumor cell basement membrane proteins.  
EHS is composed of collagen IV, laminin, perlecan, entactin, matrix 
metalloproteinase-2 and growth factors [72].  Cells growing in ECM interact with 
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each other in a natural, three dimensional way and develop similar structures to 
those observed in vivo. 
      There are two notable ways to apply extracted ECM into the generation of 
spheroid cultures.  The first method involves incorporating ECM into a gel and 
embedding the cells within the gel for growth.  The second method involves 
creating a similar gel, but instead growing the cells on top of it after 
micropatterning the surface of the gel with an array of shallow wells [73].  
Although generating spheroids in this manner does take comparatively more 
work, it is still relatively easy and thus commonly employed.  Some additional 
drawbacks include differences in composition between batches of ECM, costs of 
purchasing the ECM itself, non-uniform spheroid sizes generated, and the fact 
that the spheroids end up unevenly distributed throughout the ECM if grown 
within.  The micropatterning technique works to alleviate this problem by 
creating spheroids at specified locations [74]. 
      Biodegradable materials such as collagen, laminin and alginate may be 
fabricated into scaffolds with optimal chemistries and geometries for cell growth 
and metabolism.  Engineering scaffolds is a hybrid field of chemical and tissue 
engineering.  Cells seeded onto scaffolds may migrate between fibers, attach to 
fibers, and form 3D cellular structures in the interstitial spaces between fibers 
[75].  These materials may be designed to incorporate ECM molecules that can be 
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released to the cells over the degradation life of the scaffold, creating in vivo-like 
cues [76].  The most important parameter to control is the scaffold’s porosity as it 
dictates cellular attachment and mass transfer properties [77, 78].  Ultimately, the 
scaffold facilitates the growth of the cells into 3D structures which resemble the 
geometry of the scaffold after it has degraded and been eliminated .  Therefore, 
scaffolds are not typically used to make spheroids, but other three-dimensional 
shapes. 
      The tumor fragment spheroid model involves mechanically dissociating 
tumor specimens and using the resulting fragments to generate spheroids.  The 
cellular components of the resulting fragment spheroids often vary greatly.  
Some spheroids may contain predominantly tumor cells while others are 
comprised of a majority of stromal elements (i.e. fibroblasts, pericytes, etc.) [79]. 
      2.6.5. Hanging drop method.  The hanging drop method uses a small 
aliquot (40 μL for the Insphero system) of cell suspension pipetted into 96 
bottomless wells in a three-part culture plate.  The wells allow the droplets to 








      The cells eventually collect and form a dense, tightly-packed spheroid in 
the bottom of the droplet near the air-liquid interface.  If allowed to culture for 
long enough, the cells may even proliferate after forming a spheroid.  Droplets 
are kept moist by an absorbent pad hydrated with sterile water housed in the 
bottom part of the plate.  The third piece is a top plate, covering the apparatus 
and keeping the system moist.  The InSphero Gravity-PLUS system may then be 
wrapped in parafilm to further prevent droplet evaporation.  In addition to 
losing water, droplet evaporation creates a dangerous hypertonic environment 
for the cells.  The InSphero system also comes with a non-adhesive Gravity-
TRAP plate used to transfer spheroids from hanging drop to standard 96-well 
culture.  This plate allows for further cultures or assays to be performed. 
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      Hanging drop culture  is relatively simple and has been reported to 
generate uniform spheroids at a rate close to 100% for many different cell lines.  
Further benefits of the system include easy media changes and uniform 3D 
tissues with low variability in sizes.  Klem et al [80] reported that the tissues 
created were patho- and physiologically relevant because spheroids created their 
own ECM and displayed high levels of tissue organization characterized through 
histology.  The major drawback of this technology is the droplet size is limited to 
approximately 50 μL and creating tissues larger than 1000 μm in diameter proves 
difficult.  
      2.6.6. Limitations of spheroids.  One limit of spheroids is the time 
necessary to expand cells, form spheroids, and have them grow to sufficient size 
to develop the three typical morphological regions as observed in vivo.  
Typically, it takes 2 to 4 weeks for an aggregation of a few cells to reach the point 
of usefulness.  This process may be expedited by forcing a large number of cells 
to aggregate; however, this technique will still require a few days to one week for 
proliferative and viability gradients to develop.  There are many ways available 
that can expedite this process including 3D culturing with other reagents such as 
methylcellulose and collagen.  This has reduced spheroid formation from one 
week to as low as two days in our lab.  However, the exact roles of these 
components are unknown.  One paper reported that collagen and agarose 
64 
networks may reduce natural cellular motility through steric forces in spheroid 
models, but this occurred with increased agarose concentration, not collagen 
concentration alone [81].  Fortunately, time to complete assays on 3D cultures 
would be similar to assays involving monolayers as the screening of drugs can be 
done once spheroids are formed.  It would appear that the limitation of added 
setup time would be outweighed significantly by superior and more relevant 
resulting information.  Another limitation of spheroids is the lack of 
standardized, well characterized tumor models for use in conducting studies. 
      Finally, the 3D spheroid model will never replace animal testing in the 
drug-development process.  Even though tumor, and even normal cell models 
made with spheroids provide a myriad of new information, the system lacks the 
complexity necessary for complete study and understanding of absorption, 
distribution, metabolism, elimination and toxicity [4].  The use of 3D models for 
studying toxicity of potential compounds is speculative and there is no current 
way to extrapolate data from spheroids to in vivo systems; animal testing is not 
going away.  Microfluidic devices which incorporate and link spheroids and 
other three dimensional tissues made from cells of different organs may help to 
elucidate the relationships between such organs that are not possible in today’s 
3D culture.   
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2.7. Analytical Challenges of Spheroids 
      A major reason that promising 3D culture systems used in basic and 
applied tumor biology are not used for drug screening and other HTS systems is 
the lack of simple, controlled techniques for rapid, standardized assays.  The 
current trend in 3D culture technology has emphasized increasing the 
throughput of simple culture systems without regard for in vivo relevance of the 
resulting cultures or their ability to be easily analyzed.  Increasing throughput 
without regard to the resulting in vitro biological data recreates flawed logic in a 
similar way that monolayer culture hoped to replicate the in vivo environment. 
      Analytical protocols for high-throughput analysis of 2D cell-based screens 
are well-established and documented.  Unfortunately, translating methods 
directly to 3D setups is not straightforward as new analytical challenges are 
created in these systems [52].  For example, in the lactate dehydrogenase (LDH) 
cell viability assay, the volume of culture causes a linger in fluorescent signal 
making the data unreliable [82].  Additionally, the necrotic core of 3D cultures 
naturally creates an increase in lactate dehydrogenase enzyme which is not 
necessarily indicative of the viability of cultures.  Analyses such as screening for 
cell viability and spheroid size can be done using automated processes.  But 
beyond screening for clinically relevant drugs, limitations are encountered when 
testing for drug toxicity as drug penetration, contact-dependent multidrug 
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resistance, and oxygen deficiency create difficulties with the cultures themselves.  
These are the mechanisms we hope to capture with HTS 3D spheroid histological 
analysis.  Furthermore, mechanistic assays which explain differences between 2D 
and 3D are not readily available, and the ones that work in 2D do not always 
work when analyzing 3D cultures.  For example, researchers had difficulty 
determining the therapeutic range of irinotecan, a new anticancer drug, on 
colorectal cancer spheroids because the proper assays were not available [42].  
Others hypothesized that showing increased osteogenic properties of human 
MSC/HUVEC spheroid cocultures would not be possible with current assay 
technology [52].  As previously mentioned, controlling spheroid size, and 
therefore the presence of hypoxia in the core, can create additional variables 
which become essential parts of the assay.  In addition to researching 3D culture 
methodologies, the field must tune the respective 2D assays into the third 
dimension to make the technology truly useful for drug development. 
      Confocal microscopy is a technique that can be successfully applied to 
imaging spheroids.  Its benefits include imaging spheroids up to 320 μm in depth 
and the ability to apply live/dead and some other fluorescent stains [83].  As 
early as 1995, the potential for imaging spheroids was realized, and the ability to 
image and separate spheroids based on the three standard regions of 
proliferation around the rim, quiescence in the center, and necrotic cells in the 
67 
core was described [84].  The work showed how cells begin developing a necrotic 
core around 400 +/- 25 μm in size.  However, this technique is not as easily as 
applicable to HTS as the different layers of cells may pose an analytical challenge 
as the structures interfere with chemiluminescent signals.  Confocal microscopy 
is also tedious and expensive with a single unit costing over $500,000, and more 
if customized to suit HTS analysis.  Therefore, this technology is not available in 
many standard biology research labs.  Other researchers are currently 
developing confocal microscopy methods for rapidly measuring drug 
penetration into individual spheroids with optimism that the technique may be 
applied to HTS technologies [4].  This type of assay would show which 
compounds to have the ability to penetrate a tumor-like tissue. 
      Finally, should data be successfully collected in a HTS set up, such a large 
amount of information will require new dedicated systems for processing and 
analysis.  Fenema et al. reported in 2013 that “to the best of our knowledge, high-
throughput confocal structural analysis of 3D cultures has not yet been 
established” [52].  Some assays that have been reported to work include gene and 
protein analysis using multiplex PCR and multiplex ELISAs, respectively.  Thus, 
the paramount future challenges of spheroid HTS are assay development and 
analysis of large quantities of data. 
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      Many assays that are currently used for 2D cultures could be easily 
adapted to 3D, such as those used for cytotoxicity, proliferation, drug binding, 
apoptosis, and ATP level [4].  However, the response would be an average of all 
cells in the aggregate and information on differential, regionally based responses 
would be lost.  Standard phase-contrast microscopy in conjunction with 
computer image analysis could be used to acquire such information such as the 
growth and shrinkage of spheroids.  Furthermore, commercial automated 
microscopy systems could be fitted to rapidly analyze the effects of drugs on 
spheroid growth.  Again, these techniques would unfortunately sacrifice many of 
the advantages of the 3D spheroid model. 
      The creation of new methods to stain individual, intact spheroids and 
measure the extent of necrosis should be simple and straightforward from a 
histological perspective, but using common methods would be time consuming 
and inefficient due to processing only a handful of spheroids at a time.  This data 
would provide information on the effects of drugs on the viability of the inner 
cells of the spheroid.  Furthermore, other stains may be applied to measure 
apoptosis, proliferation and various metabolic markers that could be read by an 
image-screening system applicable to HTS format.  Additionally, assays to 
measure differing responses of subpopulations of cells (proliferating, quiescent, 
hypoxic) would significantly enhance the usefulness of MCTS [85]. 
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      MCTS may allow in vitro assays for penetration and binding of drugs in 
the 3D format.  Assays done on monolayer cultures that were difficult to adapt to 
HTS, may now be performed in HTS format.  By monitoring drug binding in 
individual tumor and host spheroids, a system may be developed to measure the 
differing binding properties of new compounds.  Dosing spheroids at different 
times would allow for the kinetic analysis of drugs and even the calculation of 
their effective diffusion coefficients [4]. 
      Horman et al showed how entire plates of spheroids could be quantified 
by optical imaging for rapid, multicolor, whole-well quantification.  However, it 
still remains to be seen how spheroids can be analyzed through histology in 
high-throughput manners [86]. 
      A recent method for toxicological and biomedical testing uses a 
bioelectrical microarray system to calculate the impedance of in vitro tissues.  
This method may be applicable to spheroid culture providing information on the 
drug activity in the spheroids.  Unfortunately this test would calculate the 
average effect on the population of cells in the spheroid, losing any regionally 
based differential responses [87].  Regionally based information is the main 
advantage of sectioning and staining spheroids in a microarray system. 
      Clearly advancements in assay technology are necessary to bring spheroid 
systems into the HTS arena.  Investing in these technologies should be seen as 
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worthwhile as there are clear advantages to HTS spheroid systems.  Screening 
protocols for measuring cytotoxicity, growth arrest and viability could be 
developed rather simply and applied to high-throughput systems.  Assays that 
work in homogenous cell population spheroids would also be applicable to co-





Methodology for the Creation of a 96-Spheroid Microarray for High-
Throughput Analysis 
 
3.1. Microarray Mold Creation 
     A positive, aluminum mold was designed in SolidWorks™ (Figure 4) and 
machined using a 5º, 1/32” tapered end mill (Ford) via a computer numeric 
controlled (CNC) process.  An end mill with 5º tapers was selected in order to 
provide relief during mold release.  The aluminum part was used to create a 
polydimethylsiloxane (PDMS) negative mold along with the Slygard ® 184 
Silicone Elastomer Kit.  A 10:1 base to curing agent ratio was used per the kit’s 
instruction manual.  This mixture was poured over the positive mold into a Petri 
dish and allowed to cure in the oven at 65ºC for a period of 24 hours.  Figure 4a is 
a three view drawing of the positive mold.  Figure 4b shows the final PDMS 
negative mold created from the aluminum part. 
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Figure 4. Microarray PDMS mold fabrication.  (a) Three-view CAD drawing of 




3.2. Culture of HTB-126 Breast Cancer Spheroids 
     Breast cancer cell line Hs 578T (ATCC® HTB-126™) was cultured with the 
following media: Dulbecco’s Modified Eagle’s Medium (Gibco) supplemented 
with 10% fetal bovine serum (Gibco), 1% Penicillin-Streptomycin (Gibco), and 
0.01 mg/mL insulin isolated from bovine pancreas (Sigma-Aldrich).  Cells were 
incubated at 37ºC with 5% CO2 and grown in 75 cm2 adherent bottom culture 
flasks (Sarstedt) until confluence.  Media changes were made every other day. 
 Cell harvesting began with aspiration of the entire culture medium volume 
followed by the addition of 5 mL of 0.25% Trypsin-ETDA (Gibco) which was 
incubated for 5 minutes at standard cell growth conditions.  The trypsinized cell 
solution was collected, combined with 5 mL of fresh culture media, and 
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centrifuged at 1500 rpm for 5 min.  The supernatant was discarded and the cell 
pellet was washed twice with 1 mL fresh culture media.  Breast cancer cells were 
resuspended in fresh media supplemented with 0.24% methylcellulose prepared 
as described in [88] and seeded at densities of 20,000 to 35,000 cells/spheroid 
using the GravityPLUS™ hanging drop system (InSphero).  Cell densities were 
verified using manual hemocytometry (Hausser Scientific).  The densities are 
equivalent to cell concentrations of 5.00 x 105 to 8.75 x 105 cells/mL for 40 μL 
drops.  The cell suspension was allowed a period of 3 days for 3D spheroid 
formation with one media change after 48 hours.  Culture plates were wrapped 
in parafilm to prevent media evaporation.  Additionally, 15 mL deionized water 
was added to the bottom chamber of the GravityPLUS™ system along with the 
humidifying pad provided by Insphero.  To change the media, a 12-channel 
multipipettor (Fisherbrand Elite) was used.  15 μm of media was removed, 
discarded, and replaced with 17 μm of fresh media containing methylcellulose. 
 A slight excess was added to make up for evaporated media.  The spheroids 
were then transferred into GravityTRAP™ plates (InSphero) as follows.  Each 
well of the GravityTRAP™ plate was pre wetted with 70 μL of 4% 
paraformaldehyde (PFA) (Electron Microscopy Sciences).  The bottom piece of 
the 96-well hanging drop GravityPLUS™ plate was removed and replaced with a 
GravityTRAP™ plate.  Once attached, 70 μL of PBS (Gibco) was added to each 
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well of the GravityPLUS™ plate using the multipipettor causing spheroid 
cultures to fall into the GravityTRAP™ plate below.  After allowing 2 hours for 
fixation, spheroids were embedded in the microarray or stored long-term at 
room temperature. 
3.3. 3D Microarray Formation 
     The microarray mold (Figure 4b & Figure 5) was filled with deionized 
water.  Microbubbles were removed using a 1 mL pipette and the microjetting 
technique as described in Figure 5a.  Removal of all microbubbles in microwells is 
imperative for successful microarray formation.  Breast cancer cell spheroids 
were then placed individually into the microwells using a 1 mL pipette and the 
gravitational transfer technique described in Figure 5b.  Arrays of 24- (4x6) and 
96-spheroids (8x12) were created using the 96-well mold.  Arrays of 24-spheroids 
were created using the central wells of the mold.  Spheroid placement was 
verified using inverted light microscopy (Carl Zeiss Axio Vert.A1).  For each 24-
spheroid microarray created, 10 random spheroids were imaged and their 
diameters were measured using the Zen 2 Imaging Suite (Zeiss) prior to agarose 
infiltration for the study of processing effects. 
     Verified arrays were ready for agarose infiltration.  This commenced with 
the removal of water from the top, rectangular portion of the mold, leaving water 
only in the micropillars (Figure 5c).  UltraPure™ agarose (Invitrogen) was added 
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to DI H2O at 3% (w/v) and boiled in the microwave until completely dissolved.  
The molten agarose was then allowed to cool to 80ºC on the lab bench.  The mold 
was infiltrated with agarose by pipette into the corner of the mold at a rate of 
approximately 0.1 mL/sec (Figure 5d).  Larger flow rates may disturb spheroids in 
microwells, causing them to become displaced.  Enough agarose should be 
added to form a slight meniscus above the height of the open mold.  A tissue 
cassette (Symport)  was then mounted as shown in Figure 6 and additional 
agarose was added to the top.  The infiltrated mold was placed in the oven at 
65ºC for 5 minutes to allow complete diffusion of water and agarose.  The 
microarray assembly was then removed and cooled at room temperature for 30-
60 minutes.  The agarose transitions from a clear liquid to a slightly translucent, 
cloudy white, firm gel when solidification is finished.  The cassette may now be 
removed carefully from the PDMS mold, bringing with it the spheroids 
embedded in the micropillars of the array.  Removal must be done slowly, 




Figure 5.  Microarray fabrication (with spheroids). Once the mold is completely filled 
with deionized water, the pipette push button is fully depressed, and then the tip of 
the pipette is submerged into the water in the mold.  Once submerged, the push 
button is released, bringing up water into the pipette tip.  The pushbutton is then 
depressed and released repeatedly while the tip is aimed at submerged 
microbubbles.  The resulting microjets will cause the successful ejection of all 
microbubbles.  (b) After successful removal of all microbubbles, spheroids are ready 
to be transferred into individual wells.  Note, the pipette tip should be trimmed 
down approximately 1mm to increase its working diameter for spheroid transfer.  
Spheroids are pipetted from GravityTRAP plates into a 1 mL pipette tip at a working 
volume of 0.1 mL.  The spheroid is visually located in the pipette tip, which is held 
horizontally.  Once visualized, the pipette tip is touched to the bottom of a single 
well of the mold and turned vertically, allowing the spheroid to sink, due to gravity, 
through the volume of water in the pipette tip.  The spheroid finally comes to rest in 
the bottom of the well after 10-20 seconds, depending on the spheroid diameter and 
density.  After successful placement of all spheroids, the microarray is then 
centrifuged at 500 rpm for 5 minutes to remove any microbubbles created during 
spheroid placement.  Additionally, this centrifugation step makes sure all spheroids 
are in contact with the bottom of the wells and in the same plane.  (c) Water is 
removed from the top, rectangular portion of the mold by placing the pipette tip in 
the corner, and slowly pipetting water at a rate of approximately 0.1 mL/sec.  Water 
is now present only in cylindrical microwells.  (d) Agarose is slowly and carefully 
pipetted into the corner of the PDMS mold so as to not disturb the spheroids in the 
microwells.  The agarose and water slowly diffuse together.  This is enhanced by 
placing the assembly in the oven at 65ºC for 5 minutes, after addition of the tissue 
cassette.  This is a critical step because it is very hard to work with the spheroids in 
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agarose directly.  Beginning with water and later adding the agarose allowed 





Figure 6. Cassette and completed microarray.  (a) Cassette (orange) placement over 
microarray which occurs after agarose addition.  Once placed, more agarose was 
added on top of the cassette to surround it with a continuous layer, securing the 
array for removal from the mold.  (b) After the agarose has been allowed to cool, it is 
carefully removed from the mold, showing the finally assembly of the spheroids 
embedded in the microarray.  Care must be taken to ensure no pillars become 




3.4. Paraffin Infiltration 
     The spheroid array, stabilized in agarose and physically fixed to a tissue 
cassette, was placed in a graded series of 100 mL ethanol, HistoClear (National 
Diagnostics) and paraffin (Fisher Histoplast LP) washes for 3 hours each on the 





Paraffin infiltration procedure 
 Solution # of washes X duration 
1 50% ethanol 1 X 3 hours 
2 70% ethanol 1 X 3 hours 
3 85% ethanol 1 X 3 hours 
4 95% ethanol 1 X 3 hours 
5 100% ethanol 3 X 3 hours 
6 HistoClear (National Diagnostics) 3 X 3 hours 
7 Paraffin (Fisher Histoplast LP) 5 X 3 hours 
 
 
      After processing, the array was placed in a cassette receiver filled with 
molten paraffin and allowed to cool to room temperature for solidification. 
3.5. Histology of Spheroid Microarrays 
     Successful alignment of the mounted cassette with respect to the 
microtome blade is absolutely crucial so that all spheroids may appear on the 
same section.  The alignment procedure used was as follows.  First, it was 
assumed that previous steps used to create the microarray resulted in an array of 
spheroids that were parallel to the front surface of the tissue cassette.  Now, the 
tissue cassette had to be aligned normally to the axis of forward translation in 
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both the vertical and horizontal directions.  Vertical alignment was done using 
the bubble level attached to the cassette receiver.  This was completed first before 
horizontal alignment.  For the horizontal alignment, a blank cassette was placed 
into the cassette receiver and the microtome blade was installed.  The receiver 
was then adjusted using an iterative process which involved setting the angle, 
and using the wheel which allows for forward translation (without the slicing 
motion), to match the blade up to the blank cassette.  The blade position was 
verified against the blank cassette at the cassette’s superior and inferior edges as 
well as in between.  Successful positioning was achieved when the blank cassette 
came into contact with the blade at exactly the same time during forward 
translation of the receiver.  Visual verification of this contact was limited in 
exactness to approximately 50 um, which proved adequate for the study.  After 
successful alignment of the blank cassette, the receiver was translated away from 
the blade, and the cassette containing the microarray was mounted.  For the sake 
of the study, it was assumed that all cassettes were manufactured identically. 
      Slices were taken using a manual microtome (KEDEE KD-2258) at 20 um 
beginning at the tip of the microarray pillars and through the distance of the 
spheroids.  The number of sections taken per block varied depending on 
spheroid diameter; however, generally a number of sections spanning a distance 
of [spheroid diameter]*150% were taken to insure that no spheroid samples were 
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left unsliced.  Sections were mounted onto adhesive microscope slides (Tru 
Scientific - TruBond 380) starting at the first appearance of agarose wells and 
concluded at the predetermined distance or once no more spheroids could be 
observed visually.  The paraffin sections were then placed in the oven at 60ºC 
overnight to increase adherence to slides before the staining procedure. 
      Slides were deparaffinized, hydrated and stained with Hematoxylin and 
















Slide deparaffinization and H&E staining procedure 
 Solution # of washes X duration 
1 HistoClear n X 15 minutes (until compete 
removal by visual inspection) 
2 100% ethanol 2 X 5 minutes 
3 95% ethanol 2 X 5 minutes 
4 DI H2O 2 X 5 minutes 
5 Hematoxylin 1 X 10 seconds 
6 DI H2O 1 X 4 minutes 
7 Bluing agent (VWR Bluing Agent RTU) 1 X 1 minute 
8 DI H2O 2 X 1 minutes 
9 95% ethanol 1 X 30 seconds 
10 Eosin 1 X 10 seconds 
11 100% ethanol 1 X 1 minute 
12 DI H2O 1 X 1 minute 




      Fluoro-Gel with TES Buffer (Electron Microscopy Sciences) was used as 









3.6. Results and Discussion 
      3.6.1. Optimization of methodologies.  Each step of the process 
underwent iterative design beginning with mold creation.  The first iteration of 
the positive mold (Figure 4a) was machined using an end mill with 1º of relief.  It 
was soon realized that regardless of agarose concentration, it was difficult to 
remove the agarose/spheroid/cassette assembly from the mold without 
fracturing pillars.  The part was re-machined with 5º of relief, greatly improving 
micropillar pullout to 90-95%. 
      Even though the literature contains some resources on breast cancer 
spheroid formation with cell line HTB-126, there were numerous engineering 
challenges associated with achieving successful culture and fixation in our 
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laboratory.  The first major problem was drop evaporation during 3D culture.  
This occurred predominantly in the drops along the outer rim of the culture plate 
even though it did effect all drops to a degree.  To combat this problem, 2% 
agarose solution was placed in the top rim of the middle dish of the 
GravityPLUSTM system.  Ultimately, this was not a great solution.  When 
InSphero changed the design of the GravityPLUSTM in the summer of 2015, this 
approach was no longer feasible.  Another attempt included hydrating the pad 
with sterile deionized water instead of PBS to increase the partial pressure of 
water in the chamber as the ions in the PBS act to trap the water to its liquid 
state.  Water reduced drop evaporation but further improvement was necessary.  
Simply adding more culture medium to deficient drops was not adequate as this 
created a hypertonic cellular environment.  The final solution was to use 
deionized water in the bottom hydration chamber and to wrap the culture dish 
in parafilm.  This combination prevented drop evaporation and actually 
increased the size of the drops at times.  Regardless, this was a key step in the 
successful culturing of spheroids. 
      Once drop volume was stabilized, the next difficulty was getting cells to 
consistently form dense spheroids instead of loose aggregates.  We hypothesized 
aggregates did not fully come together because (a) over confluence during 2D 
culture created significant numbers of necrotic cells or (b) improper culture 
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conditions did not promote aggregation.  Now, some changes were made.  Cells 
were consistently washed with PBS during each media change to remove dead or 
loosely adherent cells, and hanging-drop culture was performed with the 
addition of 0.24% methylcellulose.  Additionally, cells were only cultured to 
approximately 90% confluence to avoid necrosis.  These changes allowed for 
consistent spheroid production of over 80% (>75/96 spheroids), and on occasion 
>95%, per culture plate. 
      As previously mentioned, agarose concentrations were varied to 
determine the optimal concentration for maximizing the pullout of micropillars.  
As agarose concentration was increased, pillars formed more rigidly and were 
fractured less often.  The competing mechanism was that increasing agarose 
concentration increased the viscosity of the gel.  High viscosity agarose was 
difficult to work with especially as it cooled rapidly.  The optimal concentration 
was experimentally determined using molds with no spheroids.  It was found 
that at concentrations of 0.25, 0.50 and 0.75% the resulting gel was unable to 
properly harden for pullout.  At concentrations of 1.0 and 1.5%, the gel was able 
to harden in many wells, but did not pull out consistently.  Additionally, the 
water in wells around the outer rim of the mold did not mix sufficiently with 
incoming agarose, leading to increased fracture of edge micropillars during 
pullout.  This was due to water accumulating around the outer rim of the mold 
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as a result of surface tension.  As agarose was added to the mold with spheroids, 
its effective concentration around the rim was reduced due to the presence of 
water.  All concentrations above 1.5% tested (2.0, 3.0, 4.0%) consistently pulled 
out over 90% of pillars, with some successfully pulling out 100%.  As a result we 
elected to begin using 2% agarose with molds housing spheroids. 
      The results of embedding spheroid microarrays with 2% agarose were hit-
or-miss.  Occasionally, pullout of >90% pillars was achieved.  Often, as many as 
50% of pillars failed to be removed.  We hypothesized that a boundary layer of 
water was being created around the spheroid contributing to pillar fracture 
(Figure 8). 
 
   





      Evidence for this was seen in spheroids left behind in the mold as a result 
of fractured pillars.  The agarose around these spheroids seemed unusually 
hydrated.  Additionally, histology confirmed that agarose was not completely 
surrounding the spheroids.  We also noted that this finding may have been due 
to spheroid shrinkage during the dehydration process.  A gap could often be 
seen between the boundary layer of the spheroid and the agarose in successfully 
removed micropillars (Figure 9).  To combat this, agarose concentration was 
increased to 3%.  Additionally, after the addition of agarose and placement of the 
cassette, the assembly was incubated for 5 minutes in the oven at 65ºC to 
promote diffusion and slow cooling of the gel.  These two changes allowed for 
consistent pullout of greater than 90% of micropillars.  After successfully solving 
the problems of culture and microarray fabrication, processing and sectioning of 





Figure 9. Image of sectioned spheroid showing a gap between the boundary layer of 
a spheroid and that of the agarose well. 
 
 
      3.6.2. Quantifying the effectiveness of the 24-spheroid block system.  
The effectiveness of the system was first studied on array's of 24 spheroids (4x6).  
After sectioning each array, the best five slides were chosen for analysis.  "Best" 
was experimentally determined to be as follows.  First, ten random spheroids 
were imaged and measured before processing.  Each spheroid was approximated 
as an ellipse with measurements taken for both the long and short axis of the 
spheroid.  These were used to determine the "pre-processing average maximum 
area" of the spheroids for a given block.  Maximum in this case refers to the 
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section of a given spheroid having the largest cross-sectional area, as there could 
be 10 or more sections of an individual spheroid.  After sectioning, each spheroid 
on each section was measured.  Only spheroids with areas >25% of the pre-
processing maximum average were considered successfully processed.  The five 
sections with the greatest number of spheroids processed were considered the 




24-block study overview 
Block Pre-processing average 
maximum area (stdev) 
% recovered per section 
(out of 24) 
Post-processing 
maximum area (stdev) 
B12 1.855E5 µm2 (2.213E4) 80.8% (19.4) 1.319E5 µm2 (5.434E4) 
B13 1.698E5 (2.014E4) 90.0% (21.6) 1.152E5 (3.869E4) 
B15 1.299E5 (1.764E4) 79.2% (19.0) 9.416E4 (2.298E4) 
B17 1.959E5 (1.418E4) 86.7% (20.8) 7.900E4 (2.025E4) 
 
 
      Statistical analysis was performed between the pre-processing average 
maximum area (n=40) and the post-processing average maximum area (n=37).  
The null hypothesis was that processing has no effect on the spheroid maximum 
area.  The standard deviation of the post-processing group was determined to be 
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7.021E3.  Since the sample means were 1.728E5 (pre) and 1.312E5 (post), the Z-
score was calculated to be 5.924 standard deviations away from the pre-
processing mean.  This correlates to p=1.594E-9 ≈ 0.  Therefore, the null 
hypothesis must be rejected and we conclude that processing has a direct effect 
on spheroid area. 
      Leading hypotheses on the mechanisms effecting the system include 
spheroid shrinkage during dehydration through ethanol, and compression 
during sectioning.  Shrinkage during dehydration is straightforward.  As water is 
forced from cells in the spheroid and replaced with a less dense liquid, the 
structure naturally tends to contract, even after fixation.  This mechanism may 
also account for the separation between the boundary layers of the spheroid and 
agarose as seen in Figure 9, as the spheroid and agarose may initially share a 
boundary layer until the spheroid is shrunk by dehydration and ripped away 
from the agarose.  This theory would tend to discount the pillar fracturing 
mechanism hypothesis. 
      Compression during sectioning is less intuitive to a non-histologist.  As a 
wax section is sliced very thin, on occasion the ribbon retrieved is shorter in 
distance than the width of the block (distance of the edge normal to the edge of 
the blade is under consideration).  This results in shrinkage along the y-axis of 
the block as much as 5 or 10%.  A finite element analysis results in each element 
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      Figure 10 is a diagram which represents n consecutive sections of a 
spheroid with radius, R at a section thickness, t.  The equation along the edge of 
the circle between (0,0) and (R,R) is 
  
        
    ,     (Eq. 1) 
where 
       .     (Eq. 2)   
which simplifies to 
                .     (Eq. 3) 
The area of the resulting spheroid with radius    is 
       
  .     (Eq. 4) 
      Equations 3 and 4 were used to calculate the radii and areas of optimal 
spheroids with a known radius, R, on consecutive sections.  Note that combining 
Equations 3 and 4 and eliminating constants results in the relationship, 
     
 ,     (Eq. 5) 
which will be important in figures displaying results of sectioning (Figures 3.11-
14). 
      Figure 11 shows imaging of a single spheroid before processing (A) and on 
seven consecutive sections after histology (B-H) at 10x (scale bar, 100 µm).  Figure 
12 shows 11 consecutive sections of a spheroid after histology in color at 20x.  
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The scale bar is 50 µm.  Figure 13 shows eight sections from block 15 as viewed 
by the naked eye. 
 














      The same ten random spheroids were imaged and measured on each 
section as done for pre-processing measurements.  Measurements taken were 
used to calculate the spheroid's area approximated as an ellipse.  These areas 
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were plotted against the section numbers.  For block 15, the spheroids with 
largest area were centered to section number 9 in Figure 14.  The other spheroids 
were normalized around section number 9 keeping intact the relative number of 
sections apart.  The post-processing maximum areas were used for calculating 
column 4 of Table 1.  The area of an optimal, spherical spheroid with diameter 
350 µm was plotted for reference. 
 
 
Figure 14.  Three of the best spheroids from Block 15. 
 
 
      Figure 14 shows that spheroid area correlates well to the shape of the 
optimal spheroid curve for three different spheroids from block 15.  Spheroid 
area increases as the center of the spheroid is approached during sectioning.  
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Each section was taken at 20 µm; therefore, the total amount sectioned is 
equivalent to the product of section number and 20 µm.  The eleven sections 
taken from number 2 to number 12 in Figure 13 span a distance of 220 µm.  The 
rationale for centering the maximum area secretions to section number 9 was to 
account for tilt and inconsistencies in spheroid diameter, allowing for better 
visualization of the trend across different spheroids in the group.  In order to 
achieve all maximum spheroid diameters on a single section, the user is required 
to section the block with perfect 0º tilt5 on both x- and y-axes.  Additionally, 
initial spheroid diameters would have to be uniform with perfectly round 
geometries.  Further complications include spheroids all evenly touching the 
bottom of the mold during agarose embedding; often some become dislodged by 
the incoming agarose and rest a short distance away from the tip of the 
micropillar.  Due to these factors, it is unreasonable at this time to anticipate 
maximum area sections occurring on the same histological section as the 
variance in spheroid diameter is relatively high due to the nature of culturing 
biological samples.  To combat this, the maximum area of each spheroid was 
determined by section number, and the rest of the data was normalized (shifted) 
to the this section.  Figure 15 shows 8 different spheroids processed from Block 15 
                                                 
5 Tilt is further discussed in section 3.6.3 Tilt analysis. 
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which appeared on at least 7 of 8 sections.  The dashed line represents the 
polynomial order 2 fit of the optimal 350 µm spheroid scatter plot. 
 
 





      Figure 16 is identical to Figure 15  but contains additional polynomial 
curve fits of order two.  R2 values are displayed for reference.  Of the eight 









      Curves were fit with a polynomial function of order 2 to match the 
geometrical relationship derived in Equation 3.1.  This was done similarly in 
Figure 17 for block 17. 
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      Table 4 shows a heat map of the best five sections from each of the four 
blocks summed together for a total of 20 sections.  It would appear there is no 
direct trend for the successful processing of spheroids; although columns A-C 
were significantly more successful than D-F.  This is likely an artifact of random 
error accumulating from the following factors: sectioning beginning past the 
center of the spheroid, ellipsoidal spheroid geometry with odd orientation, or 
systematic error arising as a result of the mold, microtome or operator. 
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Table 4   




      3.6.3. 96-spheroid blocks.  Blocks of 96 spheroids were not analyzed as in 
depth as those of 24 spheroids.  However, the resulting histological sections were 
analyzed to determine the average recovery rate of spheroids between three 
different blocks.  Table 5 contains data for 96-spheroid blocks.  Slides counted had 
>25% of spheroids successfully processed (24/96).  The blocks are listed in 
chronological order.  Note improvements between early and later blocks 
showing evolution of the process.  Figure 18 shows four of the best sections from 







A B C D E F
1 18 17 16 14 16 14
2 18 17 18 17 15 15
3 19 19 19 13 13 17
4 18 20 20 15 16 18
101 
Table 5 
96-spheroid block data 













A17 7 (140 µm) 4/7 0/7 0/7 56.6/96 
(59.0%) 
A2 9 (180 µm) 0/9 0/9 0/9 36.4/96 
(37.9%) 
A3 14 (280 µm) 13/14 7/14 0/14 82.8/96 
(86.3%) 






Figure 18.  The four best sections from a 96-spheroid block, A3. 
 
 
      3.6.4 Tilt analysis.  Analysis of tilt began with deriving an equation for the 








      From the law of cosines we have the relationship, 
                                 ,     (Eq. 6) 
and from the power of a point theorem we have, 
                 ,     (Eq. 7) 
remembering that 
             and             ,     (Eqs. 8 & 9) 
the resulting length of chord AB is 
     
     
                      
.     (Eq. 10). 
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      The relationship was expanded to solve for three cases: tilt in a 24-, 48- 
and 96-block.  This was done using SolidWorksTM to setup the geometry and 
measure the relevant chords while driving the dimension of the angle.  The data 
tables are available in Appendix A.  The intersection of the zero tilt line and the 
cutting edge line was considered the "focal point of tilt."  As the angle of tilt, Ɵt 
(the angle between the zero tilt line and the cutting edge line) is increased, the 
resulting maximum spheroid diameter recovered is reduced.  This new 
maximum diameter is pictured as chord AB in the Figure 19.  In larger arrays, 
spheroids further from the "focal point of tilt" diameter's rapidly become shorter.  
The scenario was simplified to account for only the long axis, the axis requiring 
more precision to successfully cut all spheroids in plane.  It was assumed that the 
tilt along the short axis would be similar, and thus have a less profound effect 
overall.  Figure 20 shows the long axis, focal point of tilt, and resulting diameters 
for a row of spheroids sectioned at three different angles (green=0, yellow=low 
tilt, red=high tilt).  The lines below the spheroids represent the diameter of a 
spheroid sectioned using the given angle of cut (represented by color).  Notice 




Figure 20.  Cuts of tilt=0º, 0.5º and 1.0º (green, yellow, red) and the resulting 
maximum spheroid diameters (below as the length of colored lines).  Lengths are for 




      The ratio of the shortened diameter (yellow and red) to the maximum 
diameter (green) was called the area reduction fraction.  This decimal was 
subtracted from 1 to get the percentage area lost and plotted in Figure 21 versus 








      Unsurprisingly, the spheroid furthest from the focal point in 96-spheroid 
blocks increased in error the fastest; error in 24-spheroid blocks increased the 
slowest.  For 500 µm diameter spheroids in 96-blocks, Ɵt values greater than 1.0º 
completely missed the outermost spheroid.  This angle is equivalent to missing 
the mark by 255 µm on each end of the block.  Angle for 100% error in the most 
distant spheroid first occurred at 1.6º for 48-spheroid blocks and 2.25º for 24-
spheroid blocks.  These angles do not correlate with acceptable results.  In order 
to keep sectioning error below 10%, angles of 0.70, 0.55 and 0.30º must be 












Degrees of Tilt (º) 
Percentage Area Lost vs. Degrees of Cut Tilt 





      Next, tilt was quantified experimentally.  During sectioning, it was 
observed that pillars did not always show up uniformly.  Often, one side of the 
block would show micropillar wells before another side.  Within a few sections, 
all pillars would usually become present.  Assuming all pillars remained flat 
through processing, the tilt could be calculated based on vertical displacement 
(quantified by number of sections) and horizontal displacement (number of new 
pillars present).  This pattern can be observed in Figure 22 which shows the 









      Table 6 shows the experimentally determined tilt values for 4 different 
blocks.  Not all blocks showed such an obvious pattern, and others contained 
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pillars which clearly did not stay flat through processing.  Incomplete 
dehydration of the agarose microarray during initial ethanol washing steps often 





Experimentally determined tilt 
 
 
      
      Average X-tilt (the long length of the block as described in the tilt section) 
was 0.115º correlating to about 0.2% error for a 24-spheroid block, a very low 
finding.  The Y-tilt was slightly greater at 0.154º.  This error was not theoretically 
determined but is less than its equivalent 24-block X-error of 0.5%.  The reason 
for increased error is the alignment mechanism.  The methodology of alignment 
Block X-tilt Y-tilt 
B17 0.112º 0.315º 
A1 0.116 0.0749 
B5 0.0499 0.103 
B7 0.180 0.124 
Mean 0.115º 0.154º 
Std. Dev. 0.0530º 0.109º 
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correlating to X-tilt error involved placing a blank cassette in the microtome and 
comparing its orientation visually against the blade across its whole length.  This 
method allowed for very accurate alignment.  There was no way to replicate this 
alignment strategy for Y-tilt.  Y-tilt was done strictly using the bubble level 
attached to the microtome and visual inspection.  This explains the larger 
average error and standard deviation.  Overall, tilt values were very low and 
could not alone account for reductions in the percentage of spheroids recovered. 
      3.6.5. Average time and costs saved to a user versus conventional 
methods.  Conventional methods for histology of MCTS involve embedding one 
or a few spheroids in a wax block using no microarray.  The greatly increases the 
number of blocks to be cut to perform the identical study using a microarray.  
Additionally, it requires the histologist to search for spheroids during cutting 
and staining.  We propose a value proposition of using our microarray technique 
based on time and materials saved for an experiment involving 108 samples per 
patient.  The sample number is based on an experiment which explants a 
patient's primary cancer cells, creates spheroids and subjects them to 12 
treatment combinations, 3 treatment durations with a minimum of 3 replicates 





Comparison of conventional and microarray methods 
Item Conventional Methods 96-spheroid microarray 
Processing and embedding $3/specimen $100/microarray 
Unstained slides from 
paraffin block 
$3 for first slide, $1/slide 
additional (10 slides) 
$3 for first slide, $1/slide 
additional (10 slides) 
IHC stain from slide $18/slide x 10 slides $18/slide x10 slides 
Digital slide scanning 20x $6/slide x 10 slides $6 x 10 slides 




      The conventional group would need to fabricate, section and stain 108 
individual blocks, while the 96-spheroid microarray group would only need to 
fabricate 2 blocks (assuming 85% recovery, resulting in excess data). It is 
unsurprising to see that processing 96 spheroids at a time versus one spheroid is 
98.6% cheaper per spheroid.  All pricing is directly from the CHOP Pathology 
Core except for microarray processing and embedding.  This was assumed to be 
$100 (~$50/hour for two hours of labor).  The additional cost in preparing a 96-
spheroid block is more than made up for in terms of cost of raw materials and 
time.  Even if as many as five spheroids were processed in parallel bringing the 
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conventional methods' cost to $51 each, the value proposition would still be 
92.8% 
      3.6.6. Failure mode analysis.  There were numerous failure modes at each 
point in the process which could ultimately result in the lack of spheroid 
recovery.  After spheroid placement, a common occurrence was disturbance of a 
spheroid in one well due to the placement of a spheroid in an adjacent well.  This 
problem could often be corrected, but on occasion the error was uncorrectable.  
This resulted in a well with no spheroid due to dislodging.  This spheroid may 
have come to rest in no well, or more often, in another well causing a double 
spheroid well.  This failure mode was also common during agarose infiltration.  
During agarose infiltration, other modes of spheroid dislodging included 
disturbances during water removal and disturbances while placing the cassette 
and adding agarose on top.  As previously discussed, removal of the microarray 
from the mold almost always resulted in the loss of >5% of micropillars. 
      Processing had the potential for great effects on the agarose/spheroid 
microarray.  Serious care was taking to mitigate these all too common failure 
modes.  The first failure mode during processing was too rapid dehydration.  
This failure was caused by subjecting the array to too high initial ethanol 
concentrations during the dehydration steps.  The result of this failure was 
curling of the agarose array resulting in a concave shape across the micropillars.  
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Ultimately, this lead to the inability of the array to be sectioned in-plane.  A 
similar failure involved incomplete dehydration.  This allowed water to remain 
in the microarray through future processing steps, also causing warping and 
difficulty during sectioning.   
      Similar problems were encountered during the transition between 
HistoClear and paraffin wax.  Many blocks were processed through paraffin wax 
that were contaminated with HistoClear from previous blocks.  The result was 
solid blocks containing significant HistoClear.  Sections of these blocks curled up 
or fractured, and thus were not able to be mounted to slides. 
      A few additional failure modes presented during sectioning of the 
microarray itself.  The first of these, tilt, was previously discussed in depth.  
Other errors included the fracture of sections perpendicular to the blade as a 
result of a chip, dent, or a bit of wax stuck on the blade from cutting a previous 
section.    Although possible, it was difficult piece these types of sections back 
together on a single microscope slide.  Generally, these sections were lost.   
      Another failure mode occurred during transfer of the section into the 
water bath for mounting to a slide.  On occasion a section would stick to a tool, 
the user's glove, or become folded during placement into the bath.  These all 
resulted in the loss of a whole section. 
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      After baking slides, they were ready for staining.  Very few losses 
occurred during staining; although, with very low frequency, some spheroid 
sections fell off into the staining solutions.  Coverslipping occurred with no 




















Errors incurred throughout microarray fabrication and processing optimization 
Error Cause Result 
spheroid displacement disturbance due to adjacent 
spheroid placement, water 
removal, or agarose additon 
wells with two or zero 
spheroids 
fractured micropillar incomplete agarose diffusion, 
lack of removal from mold 
no micropillar and 




poor dehydration sequence swelling and warping of 
microarray 
HistoClear diluting paraffin 
wax 
failure to properly change 
HistoClear solution 
inability to section block 
tilt improper microtome 
blade/block alignment 
out of plane sectioning 
fracture of wax section 
during cutting 
chip, dent or wax bit on 
blade 
wax section split 
horizontally in two 
wax section folding or 
becoming deformed 
section stuck to tool, glove or 
folded during placement in 
bath 





Validation of Tissue Microarray - Iron Oxide Nanoparticle Penetration Study 
4.1. Experimental Procedure 
      The following procedure was used to determine the penetration and 
potential chemotherapeutic potential of 5k Da-polyethylene glycol coated 
superparamagnetic iron-oxide nanoparticles (5k-PEG SPIONs) on HTB-126 
breast cancer cell spheroids.  Both 2D and 3D culture systems were tested for 
comparison. 
      4.1.1. 2D culture and histology.  Cells were collected from one confluent 
T75 flask and resuspended in 40 mL of fresh culture medium.  In one 24-well, 
flat-bottom, adherent culture plate, 1 mL of cell suspension was added to each of 
16 wells.  Similarly, 1 mL of cell suspension was added to all 24-wells of a 
separate 24-well culture plate.  In total, 40 separate monolayers of HTB-126 
breast cancer cells were cultured.  Plates were incubated until cells reached 
confluence.  Media was changed every other day.  Four wells were fixed with 4% 
paraformaldehyde and without incubation with SPIONs (negative control).  
Fixation was performed for two hours.  Cells were washed with PBS and left to 
sit at room temperature in fresh PBS awaiting staining. 
      The remaining 36-wells contained 12 experimental groups of n=3 
consisting of three dosages (1 µg/mL, 10 µg/mL, 100 µg/mL) and four time points 
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(1d, 2d, 3d, 7d).  After incubation for the prescribed duration, cell monolayers 
were fixed for two hours in 4% PFA, washed with PBS, and hydrated with PBS 
until staining. 
      2D cultures were not embedded and sectioned, but instead stained 
directly in culture plates following fixation.  Preparation of the stain involved 
creating 20% aqueous solution of hydrochloric acid (20 mL concentrated 
hydrochloric acid added to 80 mL distilled water) and 10% aqueous solution of 
potassium ferrocyanide, trihydrate (K4Fe(CN)6·3H2O (10 g potassium 
ferrocyanide Sigma Cat# P-3289, dissolved in 100 mL distilled water).  The two 
solutions were mixed immediately before staining.  1mL of the solution was 
added to each well of the fixed 2D cultures and allowed to incubate for 30 
minutes.  The wells were then washed three times with distilled water and 
counterstained with 1 mL nuclear fast red stain for five minutes.  After two more 
washes with distilled water, plates were imaged and photographed using the 
Zeiss AX10 microscope and Zen Imaging Suite. 
      4.1.2. 3D spheroid formation and incubation.  Breast cancer spheroids 
with an initial density of 30,000 cells per 40 µL droplet were formed as described 
in 3.2 Culture of HTB-126 Breast Cancer Spheroids.  Spheroids were transferred 
with PBS to a sterile GravityTRAPTM plate without fixation using the same 
transfer technique that was used for placing spheroids into microwells (Figure 
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5b).  Due to normal losses during culture, two full plates of spheroids were 
necessary to fill one 96-well GravityTRAPTM plate with a single spheroid in each 
well. 
      The spheroids were then incubated with culture medium (DMEM 
supplemented with 10x FBS and 1x penicillin/streptomycin) containing 5k-PEG 
SPIONs received from Auburn University via Dr. Alan David's lab as described 
in [89].  Twelve experimental groups were created using two SPION dosages (1 
µg/mL, 10 µg/mL) and six incubation lengths (1 hr., 4 hrs., 12 hrs., 24 hrs., 3 days, 
7 days) for n=8 of each.  Unfortunately, not enough particles were provided for a 
third dosage group of 100 µg/mL.  Negative control spheroids were fixed 
without incubation (n=8).  Calf's liver was dehydrated, infiltrated and embedded 
with paraffin for use as a positive control in the Pearl's Prussian Blue staining 
protocol.  Upon completion of SPION incubation, each spheroid was transferred 
to a new GravityTRAPTM plate containing 4% paraformaldehyde (PFA) for 
fixation.  Fixation proceeded for 2 hours followed by removal of PFA, one PBS 
wash, and the addition of PBS for long-term storage at room temperature until 
remaining spheroids were ready for embedding into a microarray. 
      4.1.3. Microarray fabrication and histology.  Spheroid groups of n=8 
began the incubation process.  However, some spheroids disassembled and 
others were lost leaving groups of n=5 to n=8.  The remaining spheroids were 
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assembled into two separate microarrays using the center 48-wells (6x8) of each.  
Control spheroids were placed in the first four wells of the top row (wells A1-
A4).  After processing, spheroids were sectioned at 20 µm.  The best six slides 
were chosen for analysis6.  Slides #1, 3 and 5 were sent to the Children's Hospital 
of Philadelphia Pathology Core for Prussian blue staining (nuclear fast red 
counterstain) and digital slide scanning at 20x.  Slides #2, 4, and 6 were stained 
using an identical Prussian blue stain/nuclear fast fed counterstain protocol in 
our own lab.  The staining protocol from [90] begins with deparaffinization and 
hydration of sections to water.  The protocol proceeds with creating and 
combining the same two reagents (20% hydrochloric acid, 10% potassium 
ferrocyanide) as discussed in 4.1.1 2D Culture and Histology.  Hydrated sections 
resulting from sectioning of the 3D spheroid microarray were incubated in the 
mixed solution for 30 minutes.  Slides were then washed three times with 
distilled water and counterstained with nuclear fast red for five minutes.  After 
two more washes in distilled water, sections were coverslipped with aqueous 




                                                 
6 Slides were chosen so that a minimum of n=3 for each spheroid experimental group as not all 
spheroids were on each slide. 
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4.2. Data Collection 
 2D and 3D culture images were analyzed using ImageJ.  Specifically, 
images were loaded into ImageJ, converted to 32-bit/grayscale, and threshold 
analysis was used to determine the percent area stained.   
      2D culture images were analyzed using the following thresholding values 
to specifically highlight the Prussian blue stain: hue 85-128, saturation 44-134, 
brightness 0-255.  The software was used to measure the percentage of area 
stained. 
      Before analysis, 3D spheroid images were separated into four specific 
cores using Paint.net, an image editing program, as shown in Figure 23.  Core 1 
was the central region of the spheroid ranging from the center to a distance of 
0.25r.  The other cores 2, 3, and 4 were rings covering consecutive area ranges 









      No analysis was performed for Prussian blue staining.  Thresholding 
analysis between values of 67.5 and 184.5 were used to determine the degree of 
the nuclear fast red staining.  Nuclear fast red stains nuclei red and the 
cytoplasm pink.  As evident from the pictures, no positive Prussian blue staining 
was observed.  The area enclosed and percentage stained was measured for each 
core.  These percentages, along with standard deviations in the experimental 
groups, are reported in Table 9.  Averages and standard deviations across single 
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time points, individual cores, and for all samples were calculated.  These values 




Percentage of staining by cores and time points for all dosages 
 Core 1 Core 2 Core 3 Core 4 Time 
Averages 
Day 0 77.7 (12.8) 80.1 (10.4) 84.3 (9.44) 79.9 (5.94) 80.5 (8.85) 
Day 0.5 71.5 (2.58) 68.9 (2.96) 70.6 (3.71) 82.4 (7.35) 73.3 (6.77) 
Day 1 98.9 (0.806) 98.6 (0.417) 97.9 (2.23) 93.3 (3.04) 97.2 (2.86) 
Day 3 74.6 (36.9) 63.2 (30.6) 65.3 (32.2) 55.2 (40.2) 64.6 (30.8) 
Day 7 72.1 (32.6) 76.4 (17.7) 64.6 (17.0) 44.3 (12.8) 64.3 (22.3) 
Core 
Averages 





4.3. Results and Discussion 
      The following images were taken of 2D monolayer cultures after Prussian 
blue staining.  The negative control is not pictured.  Dosages increase from left to 
right while incubation times increase from top to bottom. 
 
 
Figure 24.  Staining of 2D cultures.  Rows from top to bottom are days 1-3, dosages 
from left to right are 1, 10, 100 µg/mL. 
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     Thresholding values were used to calculate the percentages stained by 




Figure 25.  Percentage staining by dosage and incubation time.  Error bars denote 




      The results show that there was no significant difference between staining 
for dosages of 1µg/mL and 10 µg/mL.  Significant differences in staining were 
observed between both 1 µg/mL and 100 µg/mL, and 10 µg/mL and 100 µg/mL 

































specific concentration which promotes increased uptake of SPIONs into cell 
monolayers.  This is an interesting result moving forward as it helps explain 
what may have been observed in 3D culture experimentation. 
      The following images (Figure 26 & 27) show a lack of positive Prussian 
blue staining across all 3D spheroid cultures, regardless of dosage or incubation 
time.  Note that between removal of the microarray from the mold, sectioning 
and slide mounting, the orientation is effectively mirrored over the y-axis as a 
result of the process.  This leaves the control spheroids (n=3 pictured in this 
section) in the top right corner of the figure.  Experimental groups begin on the 
right and move left across a single row.  It is unfortunate that not enough 
particles were provided to study the dosage of 100 µg/mL on spheroid cultures.  
It is recommended that this is the starting dosage for future experiments. 
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Figure 27. Block T2 Prussian blue stain (nuclear fast red counterstain). 
 
 
      The lack of positive Prussian blue staining in 3D culture could be 
indicative of multiple results.  One obvious cause is experimental error arising 
from improper staining technique.  This is relatively unlikely due to successful 
staining of 5k-PEG SPIONs in similar spheroids of a different cell line using an 
identical procedure.  However, we should note that these spheroids were slightly 
larger, not as densely packed, and incubated for a period of 3 days.  Figure 24 
shows positive staining for ferric ion in a rhabdomyosarcoma sarcoma (CRL-




Figure 28 .  Prussian blue stain (nuclear fast red counterstain) of a CRL-2061 
spheroid of approximate diameter of 1.2 mm. 
 
 
      Unfortunately, no breast cancer spheroids contained a similar pattern of 
SPION penetration around the periphery of the tissue.  The goal of this 
experiment was to determine penetration of these particles into different regions 
of the spheroid over time; however, this was not successful.   
     Another hypothesis for the lack of staining is particle removal through 
diffusion during microarray processing.  This would explain the presence of 
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particles in 2D and the lack of particles in 3D, as only 3D cultures were subjected 
to extended immersion in various reagents before staining. 
      Other hypotheses which explain the lack of positive ferric ion staining 
include multicellular tumor resistance.  Discussed in Chapter 2, this resistance is 
the result of many cells becoming densely packed and working together to resist 
foreign agents, including chemotherapeutic drugs.  Additionally, it is possible 
that breast cancer cell line HTB-126 does not have proteins with the ability to 
internalize SPIONs, while cells in the rhabdomyosarcoma cell line CRL-2061 are 
fully capable.  Although, this is unlikely due to positive staining in 2D and the 
fact that all human (and eukaryote cells for that matter) cells possess similar 
integral membrane proteins.  Previous research has shown successful penetration 
into cell monolayers [89].  Further experimentation needs to be performed before 
ruling out SPION penetration in 3D tissues.  On occasion, nonspecific, positive 
ferric ion staining was observed which may be attributed to contamination at 
some point along the process, processing effects, or actual particle penetration. 
      One result noted was that spheroids seemed to go through three distinct 
phases of assembly, growth and disassembly across all four cores.  The assembly 
phase can be described as the time between initiation of hanging drop culture 
and Day 0 of nanoparticle incubation.  Once spheroids were assembled, they 
were incubated with particles.  The next day saw a steady increase in spheroid 
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counterstaining density indicating cellular growth and compaction.  The next 
two staining time points, day 3 and 7, saw progressive deterioration of area 
stained in the spheroids attributed to disassembly of microtissues.  This 
deterioration was not observed in any control spheroids; therefore, this result 







A Mechanical Solution for Automated Spheroid Transfer 
5.1. Mechanical Transfer Ideation 
      The idea to automate the placement of spheroids into microwells was a 
natural technological advancement in the design of the system.  Additionally, it 
was recommended by grant reviewers as a prospective way to increase the 
innovation potential and utility of the technology.  The current system of 
spheroid transfer, although precise and with 100% success rate, is slow and very 
tedious.  An ideal system would transfer spheroids directly from hanging-drop 
culture plates and into the microarray mold with low or zero losses.  In this case, 
spheroids would need to be fixed either while in hanging-drops, or in the mold 
after transfer.  Upon successful development of mechanical transfer technology, 
such decisions could be properly tested and made.  There is a need to efficiently 
collect and transfer spheroids from culture into the microarray mold in an 
automated or mechanical fashion in order to improve the speed of the process by 
100%.  The current system takes between 1.5 and 2.5 hours to place 96 individual 
spheroids (~60-90 seconds each).  Reducing this time would greatly reduce the 
labor cost associated with microarray fabrication (Table 4). 
      Design of the system began with the consideration of three different 
transfer mechanisms.  The first design considered was a simple system to house a 
131 
96-well plate and connect it to the microarray mold using a series of small plastic 
tubes.  It would operate on the principle of spheroid transfer through 
gravitational fluid flow.  The unknown aspect of this design was whether the 
enough force could be generated to move a spheroid through a thin tube with 
water and gravity alone.  It was hypothesized that the surface tension of water 
may act to inhibit water and spheroid movement through a vertical tube due to 
the geometrical constraints of spheroid size, hanging-drop plate dimensions, and 
microarray mold geometry.   The second design considered was similar to the 
first, but would incorporate a vacuum to assist in overcoming frictional forces or 
those arising due to water tension. 
      Design number three involved building a system that would operate with 
the assistance of a centrifuge.  The governing design principle behind this device 
was to use the centrifugal force to transfer spheroids; the design would be 
required to mechanically connect hanging drop plates to the mold in a compact 
format so as to fit in the centrifuge's plate holder attachment.  The design would 
then use the force of the centrifuge to overcome other forces present and one 
place the spheroid into the bottom of each microwell.  Ultimately, it was 
determined to proceed with design one for simplicity and avoid over 
engineering.  Future iterations would consider the use of other sources of force 
for spheroid transfer. 
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5.2. Mechanical Design 
      In order to achieve the design goals discussed for design one in 5.1 
Mechanical Transfer Ideation, it was decided that the first prototype would consist 
of 4 fundamental parts: a rigid piece that fits existing pins of GravityTRAPTM 96-
well plates to collect spheroids directly from culture; a rigid piece that fits the 
existing geometry of the microarray mold, containing a channel for each 
spheroid to flow downward into the mold; a series of 96 narrow, polymer tubes 
that connect the two parts; and a water vat on top to increase the pressure head 
of the system. 
      5.2.1. Microarray base connector.  The microarray base connector was 
designed using the geometry of the microarray mold.  Figure 29a is a 
SolidWorksTM isometric view of the mold which serves as the starting point for 
the design of the microarray base connector, Figure 29b.  Figure 30 shows two 
larger isometric views of the microarray base connector.  Notable design features 
include counter bored holes which allow for the press fitting of tubes, a "clover 
leafed" geometry to mate the bottom of the part to the mold while creating ample 
open surface area for outlet water flow, pins which secure the piece directly into 
the four corner wells of the 96-well microarray mold, and a 200 µm cross shaped 
spacer at the bottom which allows for the outflow of water, but does not provide 
ample space for spheroids to jump between wells.  The base connector was 
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designed to incorporate transfer for only the center 24 wells of the hanging-drop 




Figure 29. Microarray base connector. (a) SolidWorks isometric view of the 
microarray mold, the starting point for the design of the transfer device. (b) 









      5.2.2. Hanging-drop plate interface.  The next part was designed to 
interface a Insphero 96-well hanging drop plate to a series of tubes that would 
terminate into the microarray base connector.  Figure 32 depicts an isometric 








      The most important design feature of this part is the array of 96 
countersunk holes and three pin holders (two bottom right side, one top left side) 
around the outside of the array for alignment.  These were designed to work 
with preexisting pins of the GravityTRAPTM system.  It was designed so that 
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when interfacing with a GravityTRAPTM plate, hanging spherical drops of 40 µL 
would just slightly touch the hanging-drop plate interface, causing their transfer 
to the interface.  Additionally, the geometry of the countersunk holes was 
designed to use water tension as an aid in transfer.  The geometry of the holes is 
such that a 40 µL drop will not pass through the plate without additional water 
added on top.  The countersunk holes traverse through the length of the part and 
on the bottom side are the appropriate size for press fitting the thin polymer 
tubes.  This is extremely important for functionality of the complete system.  Its 
operation will be discussed in 5.3 Automated Spheroid Transfer Operation.   
      Other design features include a channel around the array of countersinks 
which allows the press fitting of the 5.2.4 Water vat.  This channel was designed 
to house an O-ring which keeps the connection between these two parts water 
tight.  This plate also contains a hole in each corner for the addition of long 
threaded rods.  These rods support the device and allow for the control of the 
interface's height, and thus the pressure head of the system.  
      At this time, only the center 24 wells of the hanging-drop plate interface 
were machined through the part.  The remaining holes were not drilled, but the 
countersinks remain as placeholders for future design iterations.  
      5.2.3. PVC tubing.  The system was designed to include clear PVC tubing 
with inside diameter of 1/32" and outside diameter of 3/32".  Clear tubing was 
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used for visualization of flow and spheroid transfer.  The tubing was ordered 
from McMaster-Carr.  Approximately 6" lengths of tubing were used.  To install 
the tubing, the end was cut at a 45º angle to aid press fitting.  Figure 32 shows the 




Figure 32.  Three views showing the connection between the two main components 
of the design with tubes. 
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      5.2.4 Water vat.  The water vat was a late design addition once testing had 
revealed that an additional pressure head would be necessary for spheroid 
transfer.  The vat was designed to press fit to the hanging-drop interface (which 
needed slight modification), and form a water-tight seal with the help of two O-




Figure 33. Mechanical transfer system completed assembly.  
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5.3. Mechanical Spheroid Transfer Operation 
The mechanical system was designed to operate as follows: 
1. The microarray mold is prepared by filling its cavity with water and 
removing all microbubbles as described in 3.3 Microarray Formation.  It is 
then attached to the microarray base connector using four pins. 
2. After placement of the Insphero hanging-drop plate to the hanging-drop 
interface, spheroids are transferred to the interface by contact with 
hanging-drops.  Due to surface tension of the culture medium, spheroids 
and droplets remain in the counterbores of the hanging-drop interface 
part. 
3. A piece of filter paper is applied, covering all counterbores of the array.   
4. The water vat is then press-fitted into the hanging-drop interface.  It is 
slowly filled with about one centimeter of water to increase the pressure 
head, flushing the spheroids through the tubes and into the microarray 
mold.  Care is taken not to flush the interface too fast causing filter 





      In this study, a novel process for the high-throughput analysis of 
multicellular tumor spheroids was designed, refined, and fully characterized.  
The system has full capabilities to increase the throughput, speed and 
effectiveness of biomedical research on spheroid cultures.  Benefits of this system 
include increased power of study, side-by-side staining, and efficiency.   
      The system designed is not completely without error, and therefore comes 
with recommendations for the future.  The most important error factors all have 
to do with pillar pull out and orientation through processing.  Other errors, such 
as tilt during cutting, were shown to be acceptable, leading to a small amount of 
error, and thus should be considered for improvement only once permanent 
solutions to primary errors are reached. 
      The paramount issue with the system is the mold design which creates the 
geometry of the microarray.  Pillars were designed to be cylindrical, but after 
thorough testing of all system parameters (gel composition, reagents, etc.) 
experimental pullout reached a maximum of 90/96 spheroids per microarray 
(n=2).  After processing and sectioning, the maximum number of spheroids 
achieved on a single slide was 84/96 (n=1).  Additionally, the cylindrical pillars 
allowed for a relatively large area for the spheroid to move and come to rest.  The 
140 
result were imperfect columns and rows of spheroids on slides after histology.  
To solve the issue of spheroid pullout and alignment, it is recommended that a 
positive mold of an array of square pyramids be used to replace the cylindrical 
pillars.  This would allow for much larger angles of relief during pullout, and 
would also create geometry in the mold what would force spheroids to become 
centralized in each well.  This design would also increase the surface area for 
diffusion during processing, potentially eliminating processing effects, while 
promoting better mixing during agarose infiltration. 
      The SPION study showed the potential power of using a microarray 
system to study spheroids and acquire regionally based information.  Although 
no publishable results were obtained from the penetration of particles into 
spheroids, the power of the system was ascertained.  A study which previously 
would have taken a lab months to assemble, process and section 96 individual 
spheroid blocks, was reduced to the processing of just two, while adding the 
ability for side-by-side comparison of multiple experimental groups (without 
normalization each to a stained and calibrated control). 
      The study did highlight a potential therapeutic dosage range between 10 
µg/mL and 100 µg/mL for 5k-PEG SPIONs.  Within this range, there appeared to 
exist a concentration which allowed the drug to penetrate the cell membrane.  
Furthermore, even without positive staining, dosage and time combinations of 3 
141 
days and 10 µg/mL, 7 days and 1 µg/mL, and 7 days and 10 µg/mL all showed 
spheroids much less dense than their control counterparts which were 
disassembling and becoming necrotic.  The dosage and time combination of 3 
days and 1 µg/mL showed 67% normal spheroids and 33% necrotic spheroids.  
All other time points less than 3 days showed no signs of necrosis. 
      Finally, to improve the process of spheroid embedding, a design was 
successfully created that mechanically assisted spheroid transfer.  The time to 
setup and use the system was ~5 seconds per spheroid, a large reduction in time 
compared with ~60-90 seconds per spheroid using the methods described in 3.3 
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Table A.1   









0.100 0.500 0.499 0.498 
0.200 0.498 0.496 0.490 
0.300 0.496 0.491 0.478 
0.400 0.492 0.484 0.460 
0.500 0.492 0.484 0.437 
0.600 0.482 0.464 0.405 
0.700 0.475 0.450 0.365 
0.800 0.468 0.434 0.313 
0.900 0.458 0.415 0.240 
1.000 0.448 0.392 0.111 
1.100 0.437 0.365 0.000 
1.200 0.423 0.334 0.000 
1.300 0.409 0.295 0.000 
1.400 0.392 0.248 0.000 
1.500 0.373 0.183 0.000 
1.600 0.352 0.060 0.000 
1.700 0.329 0.000 0.000 
1.800 0.301 0.000 0.000 
1.900 0.270 0.000 0.000 
2.000 0.231 0.000 0.000 
2.100 0.183 0.000 0.000 
2.200 0.111 0.000 0.000 






Table A.2   
Tilt area raw data 
Degrees of 
Tilt 24 area 48 area 96 area 
0.100 0.196 0.196 0.194 
0.200 0.195 0.193 0.189 
0.300 0.193 0.190 0.180 
0.400 0.190 0.184 0.166 
0.500 0.190 0.184 0.150 
0.600 0.182 0.169 0.129 
0.700 0.177 0.159 0.105 
0.800 0.172 0.148 0.077 
0.900 0.165 0.135 0.045 
1.000 0.158 0.121 0.010 
1.100 0.150 0.105 0.000 
1.200 0.141 0.087 0.000 
1.300 0.131 0.069 0.000 
1.400 0.121 0.048 0.000 
1.500 0.110 0.026 0.000 
1.600 0.098 0.003 0.000 
1.700 0.085 0.000 0.000 
1.800 0.071 0.000 0.000 
1.900 0.057 0.000 0.000 
2.000 0.042 0.000 0.000 
2.100 0.026 0.000 0.000 
2.200 0.010 0.000 0.000 








Table A.3   
Calculated percent differences of area 
Percent Differences 







0.000 1.000 1.000 1.000 
0.100 0.998 0.996 0.990 
0.200 0.992 0.985 0.962 
0.300 0.982 0.965 0.914 
0.400 0.969 0.938 0.848 
0.500 0.969 0.938 0.762 
0.600 0.929 0.861 0.658 
0.700 0.904 0.811 0.534 
0.800 0.874 0.753 0.391 
0.900 0.841 0.688 0.230 
1.000 0.803 0.615 0.049 
1.100 0.762 0.534 0.000 
1.200 0.717 0.445 0.000 
1.300 0.668 0.349 0.000 
1.400 0.615 0.245 0.000 
1.500 0.558 0.134 0.000 
1.600 0.497 0.014 0.000 
1.700 0.432 0.000 0.000 
1.800 0.363 0.000 0.000 
1.900 0.291 0.000 0.000 
2.000 0.214 0.000 0.000 
2.100 0.134 0.000 0.000 
2.200 0.049 0.000 0.000 







Table A.4   
Calculated percent error of area 
Percent Error 







0.000 0.000 0.000 0.000 
0.100 0.002 0.004 0.010 
0.200 0.008 0.015 0.038 
0.300 0.018 0.035 0.086 
0.400 0.031 0.062 0.152 
0.500 0.031 0.062 0.238 
0.600 0.071 0.139 0.342 
0.700 0.096 0.189 0.466 
0.800 0.126 0.247 0.609 
0.900 0.159 0.312 0.770 
1.000 0.197 0.385 0.951 
1.100 0.238 0.466 1.000 
1.200 0.283 0.555 1.000 
1.300 0.332 0.651 1.000 
1.400 0.385 0.755 1.000 
1.500 0.442 0.866 1.000 
1.600 0.503 0.986 1.000 
1.700 0.568 1.000 1.000 
1.800 0.637 1.000 1.000 
1.900 0.709 1.000 1.000 
2.000 0.786 1.000 1.000 
2.100 0.866 1.000 1.000 
2.200 0.951 1.000 1.000 
2.250 0.994 1.000 1.000 
 
